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Abstract 
Body mass index and disordered eating in adolescent females with type 1 diabetes. 
Jessica Tuttman Markowitz, M.S. 
Michael R. Lowe, Ph.D. 
 
 
 
Obesity is one of the top ten global health problems as recognized by the World Health 
Organization and is an epidemic in the United States.  Type 1 diabetes is a disease in 
which disordered eating and overweight can cause significant medical comorbidities.  
The prevalence of overweight and some eating disorders are greater in adolescent females 
with type 1 diabetes than in those without the disorder.  The development of type 1 
diabetes may be affected by elevated body mass index (BMI).  In addition, the 
management of the disorder (and associated risk factors) can be affected by disordered 
eating as well as elevated BMI.  This study aimed to examine the relationship between 
disordered eating attitudes and behaviors and overweight with a number of self-report 
variables.  These included attitudes toward food, weight and dieting history, and diabetes 
treatment variables.  The purpose of the study was to better understand this population 
and begin to develop effective interventions.  Data were collected at one pediatric 
endocrinology clinic and three summer camps with the final sample yielding data from 
90 females, ages 12-19, with type 1 diabetes.  The current sample had a significantly 
higher BMI that that of a non-diabetic comparison sample.  A significant positive 
relationship was found between eating disorder characteristics and cognitive restraint, 
BMI, and weight suppression.  Those participants who reported a history of dieting 
scored higher on a measure of eating disorder characteristics than those without a history 
of dieting.  A significant positive relationship was found between BMI and appetitive 
responsiveness to the food environment, disinhibition, and BMI category at first 
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diagnosis.  Participants who reported never being overweight displayed less eating 
disorder characteristics than those who were overweight prior to diagnosis and those who 
were overweight after diagnosis.  While these results are correlational and not causal, 
they indicate that there are some easily recognized characteristics of adolescent females 
with type 1 diabetes that may predict the likelihood of problems with disordered eating 
attitudes or behaviors or problems with overweight.  The data may be used to inform 
future research, as well as have implications for the development of effective health-
related interventions with this population.      
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CHAPTER 1: INTRODUCTION 
 
The problem of obesity 
Obesity has become an epidemic in the United States.  Over two thirds of 
American adults are overweight or obese (Hedley et al., 2004) and there is no data to 
suggest that the prevalence is decreasing.  A recent study found, using self-report data, 
that from 2000 to 2005, the prevalence of obesity (BMI over 30) increased by 24%, the 
prevalence of BMI over 40 increased by 50%, and the prevalence of BMI over 50 
increased by 75% (Sturm, 2007).  In addition, a study observing the trend in BMI in the 
US estimates that by 2015 greater than 40% of men and 45% of women will be obese 
(Veerman, Barendregt, van Beeck, Seidell, & Mackenback, 2007).  Obesity is recognized 
by the World Health Organization as one of the top 10 global health problems (Kelner & 
Helmuth, 2003) and increases the risk of death from a variety of causes.  In addition, 
obesity leads to a wide range of medical comorbidities such as type 2 diabetes, 
cardiovascular disease, coronary heart disease, respiratory disease, some cancers, 
osteoarthritis, and hypertension (Calle, Thun, Petrelli, Rodriguez, & Heath, 1999; Pi-
Sunyer, 1999; Redon, 2001).  
Childhood obesity 
 Rates of obesity are not only increasing in adults, but also in children.  A study 
published in 1998 reported that approximately 22% of children and adolescents were at 
risk of becoming overweight (as defined by a body mass index (BMI) greater than the 
85th percentile) (Troiano & Flegal, 1998).  In addition to weight, waist circumference and 
waist-height ratio in children and adolescents is increasing.  From 1999 to 2004, both of 
these measures of abdominal obesity increased significantly in boys and girls (Li, Ford, 
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Mokdad, & Cook, 2006).  In a 2004 study, it was reported that from 1999-2002, 31% of 
children ages six through 19 were either overweight or at risk for becoming overweight.  
At risk for becoming overweight was defined as having a BMI for one’s age that was 
greater than or equal to the 85th percentile.  Overweight was defined as having a BMI for 
one’s age that was greater than or equal to the 95th percentile (Hedley et al., 2004).  When 
examining the cohort between the ages of 20 and 39, the number of overweight or obese 
increases to approximately 60% of the population, and after age 60, approximately 70% 
of the US population is overweight or obese (Hedley et al., 2004).  These numbers 
indicate that, while childhood obesity is a problem, the risk of being overweight or obese 
increases as people get older.  In addition, once people are overweight or obese, the 
chances of them losing weight and keeping it off are small (Sarwer & Wadden, 1999; 
Foster, Wadden, Kendall, Stunkard, & Vogt, 1996).  Therefore, it is important to address 
the issue as early as possible in order to prevent average weight children from becoming 
overweight and overweight children from becoming obese. 
 Weight-related comorbidities.  While it was previously believed that childhood 
obesity had no medical consequences, it is now known that obese children are prone to 
many of the physical ailments of obese adults (Must & Anderson, 2003).  Obesity causes 
many weight related comorbidities that have an impact on all areas of life.  Physical 
conditions include type 2 diabetes, cardiovascular risk factors, menstrual abnormalities, 
hypertension, asthma, and sleep-disordered breathing (Must & Anderson, 2003).  In 
addition to the physical ailments caused by obesity, there are also psychosocial and 
psychological ramifications.  It has been documented that children see others who are 
overweight or obese as lazy, mean, and stupid, and in general tend to assign negative 
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characteristics to those who are overweight (Staffieri, 1967; Tiggemann & Anesbury, 
2000).  In addition to social stigma, those children who are overweight may also be at 
higher risk for developing depression.  In a study of third graders it was found that higher 
BMI predicted higher levels of depressive symptoms (Erickson, Robinson, Haydel, & 
Killen, 2000).  Because childhood obesity can have such negative psychosocial 
consequences, it can be assumed that children who are overweight or obese experience 
childhood differently than those who are thin or of average weight.   
Predictors of obesity 
From an early age, children’s overweight status results from an interaction 
between their genes and their environment (Birch, 2002).  Other factors, such as 
education level and intelligence, have been identified to be inversely predictive of obesity 
(Halkjaer & Sorensen, 2004).  Living in an environment like the United States, where 
highly palatable, inexpensive food is readily available is also a likely cause of obesity.  It 
has been shown that Pima Indians, a population that exhibits a high level of obesity and 
type 2 diabetes, who live in the United States, have higher rates of obesity than those who 
live a traditional lifestyle in Mexico (Esparza et al., 2000).   
The way that parents interact with their children surrounding food may also have 
an influence on obesity.  Blass (2003) has shown that parents can give their children 
signals that indicate certain foods are “worse” than others.  A parent who tells his child 
he must eat his vegetables in order to have dessert is devaluing the vegetables and setting 
up negative attitudes toward eating vegetables in the future.  A parent can also set up 
negative eating patterns.  For example, in telling a hungry child he cannot eat until 
dinner, or forcing a child to finish everything on his plate when he is not hungry, the 
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parent is indicating that external cues are more important than internal cues in deciding 
when to eat (Blass, 2003).  Fisher and Birch (1999) examined children’s eating of snack 
foods after a meal.  They found that maternal restriction of highly palatable foods was 
positively correlated with higher energy intakes in an unrestricted setting for girls ages 3-
6.  If a child’s eating is highly influenced by the behavior of his or her parents it could be 
problematic in terms of their self-regulation of eating; learning to eat when hungry and 
stop when full.   
Other predictors of childhood obesity include having an obese mother, low family 
income, and lower cognitive stimulation (Strauss & Knight, 1999).  Among low-income 
children, having an obese mother during early pregnancy more than doubles the risk of 
obesity at two to four years of age (Whitaker, 2004). 
Type 1 diabetes 
An overview.  Type 1 diabetes, usually diagnosed in children and young adults, 
occurs when the body’s immune system destroys pancreatic beta cells.  These cells make 
insulin, which regulates blood glucose.  In 2002, approximately one in every 400 to 500 
children and adolescents under the age of 20 had type 1 diabetes (National Diabetes 
Information Clearinghouse, 2004).  After the age of 20, the annual incidence of type 1 
diabetes decreases (Diagnosis and Classification/Pathogenesis, 2004).  
While the specific cause of the disorder is unknown, it is thought that an 
interaction between a genetic predisposition to autoimmunity and an external, 
environmental trigger leads to the destruction of beta cells, which causes insulin 
production to cease (Laffel, Pasquarello, & Lawlor, 2005).  Autoimmunity occurs when 
the immune system mistakes the body’s own cells for invaders and attacks them 
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(National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2002).  In this 
case, the body destroys the beta cells.  Environmental factors may include infections 
(such as viruses), vaccinations, and dietary factors.  In addition, because the incidence of 
type 1 diabetes has increased in the past few decades in many countries, it is possible that 
some unknown factors in the environment are changing and contributing to the 
development of the disorder (Eisenbarth, 2005).   
Genetic factors play a role in the development of type 1 diabetes, although the 
strength of that role is unclear.  Eighty percent of new diagnoses report no family history 
and the identical twin concordance rate is between 30 and 50% (Laffel, Pasquarello, & 
Lawlor, 2005).  In addition, if a first-degree relative has type 1 diabetes, the risk of 
developing the disorder is greater than that in the general population (approximately 1 in 
20 as opposed to 1 in 300) (Eisenbarth, 2005).   
Prevalence.  Although only 5-10% of the population of diabetics have type 1 
diabetes (National Diabetes Information Clearinghouse, 2004), incidence is increasing 
and there has been a parallel increase in type 1 diabetes with the increase in type 2 
diabetes (Kibirige, Metcalf, Renuka, & Wilkin, 2003).  The majority of non-Hispanic 
white children with diabetes in Europe and the United States have type 1 diabetes (greater 
than 90%).  In African-American and Hispanic-American children with diabetes, about 
half have type 1 and the rest are believed to have early onset type 2 diabetes (Eisenbarth, 
2005).  Therefore, although the prevalence of type 1 diabetes in the general population is 
not large, it represents a major proportion of those children with diabetes, and is a 
growing population.   
 6
Progression and physiology of the disease.  Type 1 diabetes can develop at any 
age.  Its development begins with an interaction between a genetic susceptibility to 
autoimmunity and an external, environmental trigger (Eisenbarth, 2005; Laffel, 
Pasquarello, & Lawlor, 2005).  This combination of factors leads to autoimmune 
destruction of the insulin-producing beta cells in the pancreas (Eisenbarth, 2005; Laffel, 
Pasquarello, & Lawlor, 2005).  While genetic susceptibility is one factor in the 
development of the disease, having this susceptibility does not ensure the development of 
the disease, as evidenced by twin studies (Eisenbarth, 2005).   
The classic symptoms of type 1 diabetes can be conceptualized in four stages 
(Laffel, Pasquerello, & Lawlor, 2005).  In the Onset stage, symptoms manifest such as 
increased thirst, increased urination, and weight loss despite increased appetite.  The 
Honeymoon stage of the disease results after insulin therapy begins.  In this stage, the 
remaining beta cells regain functional capacity and produce some insulin for a short 
period of time.  The third stage, Intensification, is when the destruction of beta cells 
continues and control of blood glucose becomes more difficult.  The fourth stage is Total 
Diabetes when all of the beta cells are destroyed, resulting in total insulin deficiency 
(Laffel, Pasquerello, & Lawlor, 2005).  Once beta cells are completely destroyed, type 1 
diabetes has developed, and the disease must be treated with insulin injections for the 
duration of one’s life. 
Type 1 diabetes is a chronic disease that results in hyperglycemia.  Once 
pancreatic beta cells are destroyed, the body can no longer produce insulin, which 
regulates blood glucose.  Because of this, energy metabolism is altered, affecting 
metabolism of carbohydrate, protein and fat (Laffel, Pasquarello, & Lawlor, 2005).  Only 
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by injecting the body with insulin can a person with type 1 diabetes regulate their blood 
sugar effectively.        
Morbidity and mortality.  When well-treated with intensive therapy, those with 
diabetes can reduce the risk of development and progression of long term complications 
(Nathan, 2005).  However, many comorbidities are more likely to be seen in those with 
diabetes than in those without the disorder.  These include heart disease, stroke, high 
blood pressure, blindness, kidney disease, nervous system disease, amputations, dental 
disease, and complications of pregnancy.  In addition, people with diabetes are more 
susceptible to many other illnesses and may have a worse prognosis once other illnesses 
are acquired (National Diabetes Information Clearinghouse, 2004).  Those with diabetes, 
as well as their relatives, have increased risk for a number of autoimmune disorders, 
including Addison’s disease, celiac disease, thyroid autoimmunity, pernicious anemia, 
and two major polyendocrine syndromes (Eisenbarth, 2005).   
Diabetes (combined types 1 and 2) was the sixth leading cause of death listed on 
U.S. death certificates in 2000 and is also likely to be underreported as a cause of death.  
The overall risk for death among people with diabetes is about twice that of people 
without the disease (National Diabetes Information Clearinghouse, 2004).   
Treatment.  While there are no known ways to cure this disorder, people with type 
1 diabetes have a variety of treatment options, all of which include taking insulin or an 
insulin analog via injection on a daily basis.  The general goal of treatment is to bring 
metabolic functioning back into balance while avoiding symptoms such as hyperglycemia 
and hypoglycemia (Laffell, Pasquarello, & Lawlor, 2005).   
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One important aspect of diabetes treatment is self monitoring of blood sugar 
throughout the day.  In addition, there are many different variations of insulin treatment 
for those with type 1 diabetes.  Different types of insulin can be combined into one 
injection, different types of insulin can be used alone throughout the day, and insulin can 
be continuously injected into the body by using an insulin pump.   
Different types of insulin have different onset times, different peak times, and 
different durations of action.  The shortest onset insulin (insulin aspart) takes 5-10 
minutes to act, peaks in 1-3 hours, and has a duration of 3-5 hours.  The slowest onset 
insulin (ultralente) takes from 4-6 hours to act, peaks at 8-20 hours, and has a duration of 
20-24 hours.  Most children with type 1 diabetes require two to three shots a day of a 
mixture of rapid and intermediate or long-acting insulin in order to maintain good 
glycemic control (Laffell, Pasquarello, & Lawlor, 2005).   
While most people with diabetes still take multiple injections throughout the day, 
another option is use of an insulin pump, which is quickly growing in popularity within 
the pediatric population (Laffell, Pasquarello, & Lawlor, 2005).  Insulin pumps are 
devices that provide a continuous flow of insulin throughout the day through a plastic 
shunt that is inserted into the patient’s abdomen, thigh, upper hip, or upper arm, and is 
changed every two to three days.  The insulin is stored in a beeper-like device that the 
patient wears externally.  In addition to the continuous supply of insulin, the patient 
manually administers boluses of insulin at the time of meals and snacks and if blood 
glucose levels are higher than usual.  This treatment is able to mimic the actions of a 
working pancreas better than multiple-shot treatment.  With pump treatment, it is 
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necessary to monitor blood glucose multiple times a day, count carbohydrates, and match 
insulin and activity with intake (Laffell, Pasquarello, & Lawlor, 2005).   
New and future treatments for type 1 diabetes 
 While the current gold standard of treatment for type 1 diabetes is insulin, there 
are new and developing therapies for the treatment of this disorder.  
 Continuous glucose monitoring.  One new development in the treatment of 
diabetes is continuous glucose monitoring.  Glucose monitors are connected to the body 
and take continuous readings of blood glucose levels.  Some of these systems are 
designed to work with an insulin pump in order to better approximate a working 
pancreas.  These continuous monitoring systems include optional alarms for low and high 
glucose levels, as well as generate charts and other information about levels of blood 
glucose (REAL-Time Continuous Glucose Monitoring, 2008).   
 Insulin analogs.  New insulin analogs have been developed (insulin detemir and 
insulin glulisine) that may have desirable properties that insulin does not have.  Insulin 
detemir was approved by the FDA in June, 2005 and is marketed under the brand name 
Levemir (U.S. Food and Drug Administration, 2005b).  Insulin detemir was developed to 
replace long-acting insulin (such as NPH) and has been shown to offer effective glycemic 
control with lower risk of nocturnal hypoglycemia and less weight gain than seen with 
human NPH insulin.  In addition, it has been proven to be as safe.   
Insulin glulisine has also been approved by the FDA (April, 2004) and is 
marketed under the brand name Apidra (U.S. Food and Drug Administration, 2004).  
Insulin glulisine is a rapid-acting insulin analog that has been shown to have no safety 
issues (Emerging Therapies, 2004).       
 10
 Alternative insulin delivery systems.  While currently insulin must be taken via 
injection, there are other options in development such as pulmonary insulin and 
peritoneal insulin.  Pulmonary insulin is inhaled and has been shown to be as effective as 
subcutaneous insulin regimens in those with both type 1 and type 2 diabetes.  In addition, 
patients generally prefer inhaling insulin as compared to taking it via injection.  The 
negative side effects of pulmonary insulin may include hypoglycemia, as well as mild 
changes in pulmonary function (Emerging Therapies, 2004).  Pfizer and Aventis 
developed a pulmonary insulin and completed clinical trials on a product they called 
Exubera.  Exubera was approved by the FDA in 2006 (FDA News, 2006) but was 
withdrawn from the market in October, 2007 due to low interest in the product (Exubera - 
inhaled insulin for type 1 and type 1 diabetes, n.d.). 
 While the external insulin pump is a well-established insulin delivery system, 
continuing research is examining an implantable insulin pump.  In addition, a specially 
formulated type of insulin has been developed for use in this pump to last for two to three 
months between refills.  Benefits of this insulin delivery system include a decrease in 
severe hypoglycemia, possible physiological lipid metabolism, and increased quality of 
life (Emerging Therapies, 2004).  Medtronic, a company that makes external insulin 
pumps, has created an implantable pump, called the Medtronic MiniMed 2007 
Implantable Insulin Pump which is currently available in the European Union, but not yet 
available for use in the US (Medtronic, 2005). 
 Other methods of insulin delivery that are under development are an insulin patch, 
insulin pills, and an insulin spray (mouth and nose sprays are both being developed).  In 
addition, an artificial pancreas, which would be a surgically implanted device to imitate 
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the action of a working pancreas, is also under development (Alternative Devices for 
Taking Insulin, 2006). 
 Alternatives to insulin.  Because not all people with type 1 diabetes are able to 
successfully gain glycemic control with the use of insulin, other options are being 
explored.  Amylin is a neuroendocrine hormone that complements the effects of insulin 
and is naturally co-secreted with insulin.  A synthetic version of this hormone, 
pramlintide, has been developed to be injected concurrently with insulin.  Studies have 
shown that this combination of treatments may help those with type 1 diabetes who have 
not been able to gain optimal glycemic control with insulin treatment alone.  In addition, 
pramlintide has also been shown to cause weight loss in overweight and obese patients 
and not cause weight gain in normal weight patients (such as insulin treatment alone may 
cause) (Emerging Therapies, 2004).  Pramlintide was approved by the FDA in March, 
2005, and is marketed under the name Symlin (U.S. Food and Drug Administration, 
2005a). 
 Another non-insulin therapy is islet neogenesis-associated protein (INGAP), 
which is a peptide that can stimulate islet cell neogenesis and lower blood glucose.  
Animal trials have shown a reversal in type 1 diabetes by stimulating the growth of new 
islet cells.  Trials are currently underway with humans (Emerging Therapies, 2004). 
 Islet transplantation is another emerging treatment for type 1 diabetes.  While 
there are still many complications (i.e. hepatic bleeding, rise in liver enzymes, need for 
statin therapy), this treatment has been shown to be effective.  At one year post-
transplant, more than 80% of patients have achieved insulin independence with 
normalization of glycemic control.  Because of the many possible side effects, this 
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treatment is currently only recommended for situations where the benefits of glycemic 
control are greater than the risks of transplant.  Ongoing studies are further examining 
this treatment.  In addition, while islet cells are currently transplanted from cadaver 
pancreases, research is examining the use of other insulin-producing tissue in order to 
treat the large number of people who could potentially benefit from this treatment 
(Emerging Therapies, 2004). 
 Pancreas transplantation is another option for treatment of diabetes and has 
positive outcomes in the majority of cases.  This surgery is often done at the same time as 
a kidney transplant for a diabetic patient who also has kidney failure.  However, it is 
increasingly being performed on those who do not have the need for a kidney transplant 
(Pavlakis & Khwaja, 2006).  
Vaccine to reverse diabetes.  In March, 2008, researchers at Massachusetts 
General Hospital commenced a phase 1 clinical trial with a vaccine that has been shown 
to reverse diabetes in mice.  The vaccine is widely used for tuberculosis and in animal 
studies was shown to reduce the abnormal immune cells that diabetics have which attack 
and destroy the cells of the pancreas that produce insulin (MGH initiates phase I diabetes 
trial, 2008).  While it is unclear whether this treatment will be effective in human trials, it 
is an enormous step in the development of new diabetes treatments. 
Compliance with treatment in adolescence   
Glycemic control is not optimal in the pediatric population.  This is true in 
pediatric diabetes centers worldwide (Laffel, Pasquarello, & Lawlor, 2005).  One way to 
measure long term diabetes management is by testing Hemoglobin A1c (HbA1c).  This is 
a blood test that measures the amount of glycosylated hemoglobin in the blood and gives 
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an indicator of diabetes management over time (Medical Encyclopedia: HbA1c, n.d.).  In 
those who do not have diabetes, normal HbA1c levels are 5% or less.  The National 
Institutes of Health recommend that HbA1c values should be at 7% or below for those 
with diabetes in order to reduce the risk of long-term diabetes-related complications 
(Medical Encyclopedia: HbA1c, n.d.).    
Recommendations for HbA1c levels may differ by age, however.  Laffel and 
colleagues (2005) recommend that HbA1c goals range from 7-9% for toddlers and 
preschoolers, 8% or less in school age children, and 7% or less in adolescents and young 
adults.  In a recent study of 300 children with type 1 diabetes only 33% attained an 
HbA1c level below 8.1%.  These results are similar to other studies conducted worldwide 
(Laffel, Pasquarello, & Lawlor, 2005). 
Two factors that affect glucose control during adolescence are lack of compliance 
with treatment regimens and the changing hormones of puberty.  In one study of 900 
people with diabetes from ages 15 to 45, the highest levels of HbA1c were found in those 
ages 16 to 20 (Laffel, Pasquarello, & Lawlor, 2005). 
Diabetes and psychological issues during adolescence.   
There are many psychological issues that people with diabetes face.  Adolescence, 
a time that is difficult for most children, may pose unique challenges for those with the 
disorder.   
During this difficult period of time, adolescents with diabetes tend to have worse 
metabolic control than they did prior to this period.  This is due to both hormonal changes 
and changes in self-care.  In addition, many adolescents with diabetes conceal their 
diagnosis because they are worried about the ramifications.  Many do not tell their friends 
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about the disorder, and some believe that their friends would like them more if they did 
not have diabetes.  Furthermore, some adolescents skip injections because they do not 
want to draw attention to themselves.  It has been shown however, that peer and family 
support can be effective in integrating diabetes care into the daily life of adolescents 
(Anderson, Goebel-Fabbri, & Jacobson, 2005).   
Another factor that may affect diabetes care in adolescents is depression.  A 
recent study (Hood et al., 2006) found that the prevalence of depression in adolescents 
with type 1 diabetes was almost double the prevalence of that estimated in the general 
population of this age group.  Their findings indicated that females were more likely to 
have elevated depression scores than males, and higher levels of depressive symptoms 
were associated with less frequent monitoring of blood glucose and poorer glycemic 
control.     
Prevalence of eating disorders in type 1 diabetes 
Binge eating, eating disorder-not otherwise specified (ED-NOS) and subthreshold 
eating disorders have been found to be more common in adolescent girls with type 1 
diabetes than age-matched controls (Nielsen, 2002; Jones, Lawson, Daneman, Olmsted, 
& Rodin, 2005; Colton, Rydall, Olmsted, Rodin, & Daneman, 2004).  Prevalence rates, 
however, vary widely between studies and are as high as 16% (Kelly, Howe, Hendler, & 
Lipman, 2005).  A meta-analysis (Nielsen, 2002) of published studies looking at the 
relationship between eating disorders and type 1 diabetes found that while anorexia 
nervosa is not more prevalent in those with the disorder, bulimia nervosa, ED-NOS, and 
subthreshold eating disorders are.  Because those with type 1 diabetes tend to be heavier 
than their non-diabetic counterparts (Ingberg, Sarnblad, Palmer, Schjvarcz, Berne, and 
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Amant, 2003; Bryden, Peveler, Neil, Fairburn, Mayou, & Dunger, 1999; Peveler, 
Fairburn, Boller, & Dunger, 1992) however, we cannot conclude that the diabetes (and 
not other factors related to their weight) is the cause of the eating disturbances.   
Jones and colleagues (2000) studied 356 females ages 12-19 with type 1 diabetes 
and 1,098 age-matched non-diabetic controls.  Eating disorders were assessed using 
DSM-IV criteria.  Diabetic participants reported more binge eating and less dieting for 
the purpose of losing weight than controls.  In addition, participants with diabetes were 
2.4 times more likely than controls to have an eating disorder, with ED-NOS being the 
most frequent diagnosis and anorexia nervosa not being diagnosed at all in either those 
with diabetes or the control group.  Ten percent of those in the diabetic group met DSM-
IV criteria for an eating disorder, while only 4% met criteria in the comparison group.  
Diabetic participants were also 1.9 times more likely to have a subthreshold eating 
disorder than control participants (14% in the diabetic group versus 8% in the comparison 
group).  BMI was not controlled for in this study.  Those subjects with type 1 diabetes 
had significantly higher BMIs than controls (22.7 vs. 20.06, p < .001). 
Colton and colleagues (2004) compared eating disturbances in 101 girls, ages 9-
14 with type 1 diabetes and 303 age-matched female control subjects.  Eating disorder 
status was assessed using the Children’s Eating Disorder Examination (cEDE) interview.  
They found that significantly more diabetic girls reported currently engaging in two or 
more disturbed eating behaviors (8% versus 1%, p < .0005), with the most common 
combination being strict dieting with intense, excessive exercise for weight control.  
Exercise was a more common weight control behavior in diabetics, while dieting was a 
more common weight control behavior in non-diabetics.  Binge eating was more common 
 16
in those with diabetes.  However, the total composite score on the cEDE was similar in 
the two groups and there were no diagnoses of anorexia nervosa or bulimia nervosa in 
any of the participants.  In this study, among those with diabetes, BMI was higher in 
those with an eating disorder than in those without an eating disorder.  However, BMI did 
not differ significantly between those participants with and without diabetes.     
Interestingly, while Colton and colleagues found differences between the groups, 
the differences were not as striking as those found by Jones and colleagues, who studied a 
group of older adolescents.  The difference in results may be due to the fact that in the 
general population, most eating disorders are not developed until mid to late adolescence 
or early adulthood (American Psychiatric Association, 2000).  
Neumark-Sztainer and colleagues (1996) examined eating disordered behaviors in 
adolescents who reported they had diabetes (did not specify type 1 or type 2) on a 
statewide health survey and compared them with adolescents without chronic illness and 
matched for socioeconomic status.  They found that binge eating and purging were more 
prevalent among females (and males) with diabetes than among the comparison group.  
In addition, they found that, while there were no differences in BMI between the two 
groups, perception of overweight and weight dissatisfaction were higher among the 
females with diabetes than in those without the disorder, and that one predictor of binge 
eating and purging in females with diabetes was weight dissatisfaction. 
In addition, those with type 1 diabetes have the opportunity to control their weight 
by misusing insulin, a method which is not available to those without the disorder.  In one 
study, the second most common weight loss behavior reported in adolescent girls with 
type 1 diabetes was deliberate insulin omission (Jones, Lawson, Daneman, Olmsted, & 
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Rodin, 2000).  Jones and colleagues found that diabetic adolescent girls with eating 
disorders had significantly higher HbA1c compared with those without an eating disorder 
(p = .04), pointing to the harm that eating disorders can have on this population.  High 
HbA1c levels (indicating poor metabolic control) can lead to long-term diabetes-related 
complications (Medical Encyclopedia: HbA1c, n.d.). 
A recent prospective follow-up study (Goebel-Fabbri et al., 2008) found that over 
time, insulin restriction increases risk of mortality.  Participants were first evaluated 
eleven years prior and were assessed on a variety of diabetes-related variables, including 
eating disorder symptoms.  Insulin restriction was reported by 30.5% of the women who 
participated in the original study.  Of the 390 original participants, 234 were assessed at 
the second time point.  Of these women, 30% had reported insulin restriction at baseline.  
In addition to reporting more diabetes-related complications, those who restricted their 
insulin at baseline had more than a threefold increase in the relative risk of death during 
the eleven year study period. 
Another recent study (Howe, Jawad, Kelly, & Lipman, 2008) examined weight 
perception and satisfaction, scores on the Diabetes Eating Problem Survey (DEPS), 
prevalence of weight-control behaviors, and associations of the DEPS and weight-control 
behaviors with a number of variables.  Participants were 295 children and adolescents 
who had been diagnosed with type 1 diabetes for at least one year and who were older 
than 11 years.  Participants completed a number of measures examining manipulation of 
diabetes regimen for weight control (DEPS), weight perception and body satisfaction, 
and weight control behaviors.  HbA1c levels, height, and weight were collected from 
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medical charts.  Mean age of participants was 14.9, mean age at diagnosis was 8.4, and 
mean BMI was 23.3.   
Howe et al. (2008) found weight satisfaction and HbA1c significantly predicted 
DEPS.  Scores on the DEPS were significantly associated with weight perception.  
Approximately 30% of participants reported currently trying to lose weight and 
approximately 27% reported that they had dieted in the past year.  Interestingly, 
approximately 47% of participants responded positively to the statement “I feel that it’s 
difficult to lose weight and control my diabetes at the same time.”  Age-related effects 
were also found; the mean age for those who reported fasting, skipping meals, and 
increasing smoking as methods of weight control was older (significantly so) than for 
those participants who did not report these behaviors.  Not surprisingly, mean BMI was 
significantly higher for participants who reported weight-control behaviors.  In addition, 
Hba1c was significantly higher for those participants who reported using insulin omission 
to lose weight, as well as those who reported skipping meals to lose weight than for those 
participants who did not report these behaviors. 
Prevalence of overweight and obesity in type 1 diabetes 
Not only do adolescent girls with type 1 diabetes have a higher prevalence of 
eating disorders, but girls with type 1 diabetes have also been shown to have heavier 
relative weights than age-matched controls (Ingberg et al, 2003; Bryden et al, 1999; 
Peveler, Fairburn, Boller, & Dunger, 1992).   
Ingberg and colleagues (2003) studied 18 post-menarcheal adolescent females, 
ages 16-19, who had type 1 diabetes since childhood, and compared them to age-matched 
controls.  Seventeen of the participants with type 1 diabetes were treated with multiple 
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injection therapy with human regular and NPH insulin.  One was treated with the insulin 
pump.  
Measurements were conducted after an overnight fast and included dual-energy 
X-ray absorptiomery (DXA) anthropometry and skinfold measurements.  DXA is a 
validated method to assess body composition in which body measurements are taken 
(Ingberg et al., 2003).  They found that on average, the BMI of adolescent girls with type 
1 diabetes was significantly higher than the controls (2.7 kg/m2 higher, approximately 11 
lbs. difference).  The average BMI of the diabetic group was 26.3, which is considered 
overweight, and the average BMI of the comparison group was 23.6 which is considered 
normal weight.  The overweight was almost entirely made up of increased fat mass, with 
the distribution of the fat mass increased in the upper part of the body.  Proportion of 
body fat measurements calculated from skinfold measurements showed that proportion of 
body fat was significantly higher in the diabetic participants (40.2% vs. 29.1%).   
DXA measurements showed that those participants with diabetes had significantly 
higher total fat mass (5.3 kg higher), that proportion of body fat was also significantly 
higher in the diabetic participants, and that those with diabetes had significantly higher 
amounts of arm and torso fat than controls (Ingberg et al., 2003).  Although Ingberg and 
colleagues did not control for BMI differences between the two groups, the finding that 
type 1 diabetics have a higher proportion of body fat may indicate that type 1 diabetes 
makes one more prone to fat gain.    
The finding that participants with diabetes had a different distribution of body fat 
is important because the distribution of fat can have significant implications for health.  
Central obesity occurs when body fat is centered in the abdominal area and the upper 
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body and is measured using a waist to hip ratio.  If this ratio is above 1.0 in Caucasian 
men and 0.85 in Caucasian women, a person is considered to have central obesity.  This 
type of obesity is associated with higher risks for disease compared to those who may 
have the same BMI but a different distribution of body fat (Bjorntorp, 2002).  Therefore, 
adolescent females with type 1 diabetes who are overweight may be even more at risk for 
certain health problems because of the distribution of their body fat.  In addition, central 
obesity is associated with insulin resistance in healthy adolescents (Arslanian & 
Suprasongsin, 1996).  If this also applies to adolescents with type 1 diabetes, it could 
affect the amount of insulin needed in order to successfully gain glycemic control.   
Bryden and colleagues (1999) conducted a long term study of adolescents 
between the ages of 11 and 18 and assessed for, among other variables, eating disorders 
(using the Eating Disorder Examination; EDE) and BMI.  Participants were measured at 
baseline and again eight years later.  Sixty-five of the original 76 participants were 
assessed at time two (39 males, 26 females).  They found that at baseline, the BMI of the 
male participants was just slightly above normal, while at follow-up the mean BMI was 
significantly higher than normal.  Females, on the other hand, had significantly greater 
BMI than normal at both baseline and follow-up.  During the study period, males gained 
an average of 3.9 BMI points (20.3 kg) and females gained an average of 2.0 BMI points 
(8.4 kg).   
Onset of eating disorders and obesity in type 1 diabetes 
The age of onset of diabetes may have implications for the development and 
trajectory of eating disorders (Takii, et al, 1999).  Takii and colleagues examined the 
differences between bulimia nervosa and binge eating disorder in 33 type 1 diabetic 
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Japanese females.  These two groups were compared to each other and a control group 
with type 1 diabetes who did not have eating disorders (n = 32) on a number of variables.  
They found that those in the bulimia nervosa group had significantly earlier onset and 
longer duration of both type 1 diabetes and binge eating than those in the binge eating 
disorder group.  Those in the binge eating disorder group had a significantly higher BMI 
than those in the other two groups; however, all three groups were within the normal 
range for BMI. 
Effects of eating disorders and obesity on type 1 diabetes development 
 While there is no evidence that having an eating disorder affects type 1 diabetes 
development, there are studies that point to the effect of being overweight or obese on the 
development of type 1 diabetes.  Several studies have shown that those who develop type 
1 diabetes have higher BMIs in early childhood than those who do not develop the 
disease.   
Johansson, Samuelsson, and Ludvigsson (1994) examined this relationship in 297 
children who had been diagnosed with type 1 diabetes before the age of 15 and 792 
controls who were matched on year of birth, sex, and geographical region.  Height and 
weight information was taken from files on each child that existed at child welfare 
clinics.  While those who developed diabetes weighed slightly less at birth, their weight 
gain at 6, 9, 18, and 30 months of age was significantly greater than the control children 
(p < .02).  While exact weight differences were not given (the authors used standard 
deviation scores from Swedish growth charts), approximate weight differences were.  
The largest difference in weight between the two groups occurred at 30 months of age 
and was .50 kg (1.10 lbs).  Therefore, while the differences in weight were statistically 
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significant, the clinical significance of the difference in weight gain is actually quite 
small.  The authors conclude that early weight gain appears to be a risk factor for the 
development of type 1 diabetes.   
 In a retrospective study, Hypponen et al. (1999) examined 435 diabetic 
participants and 386 control participants less than 15 years of age.  At least three weight 
measurements were obtained from the first year of life.  They found that diabetic girls 
had significantly greater body weight at 1 month of age (p = .04) than control participants 
and that the difference increased from 1 month to 7 months of age (p = .0006).  The 
difference in weight between the male participants remained stable during infancy and 
was smaller (p = .09). 
 In a follow-up study, Hypponen et al. (2000) examined 586 diabetic children (less 
than 15 years old) and 571 age and sex-matched control participants.  They found that 
both boys and girls who developed the disease were relatively heavier (weight in relation 
to the mean weight for height and sex using Finnish growth standards) throughout 
childhood than the control children (prior to developing type 1 diabetes).  They also 
found that obesity after 3 years of age was associated with a more than twofold risk of 
developing type 1 diabetes.   
Kibirige and colleagues (2003) examined the question of whether children who 
were heavier developed type 1 diabetes at a younger age.  They examined 94 children 
ages 1-16 years old with type 1 diabetes.  They examined the relationships between 
overweight and age at diagnosis by measuring birth weight, weight change since birth, 
and weight and BMI at diagnosis.  All measurements were reported as the standard 
deviation score (SDS) from the 1990 U.K. growth standards.  They found evidence to 
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suggest that, in fact, age at diagnosis is a function of body mass, with a higher BMI 
correlating with an earlier age of diagnosis.     
While most of these studies collected data retrospectively, they were in fact 
examining BMI prior to diabetes diagnoses prospectively since they collected BMI data 
from before the diagnosis occurred.  Therefore, early overweight may either increase a 
predisposition to develop type 1 diabetes or speed the development of the disorder.   
Type 1 diabetes and the development of eating disorders and obesity 
Effects of type 1 diabetes on the development of eating disorders.  While it is 
unknown why eating disorders are more prevalent in those with type 1 diabetes than in 
those without the disorder, it is theorized that a number of unique aspects of the 
management of type 1 diabetes may influence the development of eating disorders.  
These include the increased emphasis on food, weight regulation, eating patterns and 
dietary intake, the cycle of weight loss at disease onset and subsequent weight gain with 
insulin treatment, and dietary restraint required for successful management of the 
disorder (Mellin, Neumark-Sztainer, Patterson, & Sockalosky, 2004; Jones, Lawson, 
Daneman, Olmsted, & Rodin, 2005).   
One eating disordered behavior, insulin under-dosing, omission, or misuse, is 
unique to those with insulin dependent diabetes.  This behavior is often used in order to 
help those with type 1 diabetes lose weight.  In this behavior, a person either intentionally 
takes less insulin than indicated by blood sugar and amount of food eaten or does not take 
any insulin at all.  A meta-analysis of eating disorders in females with type 1 diabetes 
(Nielsen, 2002) found that females engage in this behavior more than males and that 40% 
more eating disordered females with type 1 diabetes engage in this behavior to lose 
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weight than non-eating disordered females with type 1 diabetes.  While the percentage of 
adolescent females with type 1 diabetes who admit to insulin omission varies, on average, 
it is approximately 30% (Peveler et al., 2005; Bryden et al., 1999). 
 Effects of type 1 diabetes on the development of obesity.  The way diabetes is 
managed may have an effect on BMI.  Kulenovic, Rasic, & Grujic (2004) found, in a 
sample of 52 participants with type 1 diabetes, that those who were treated with two 
doses of insulin a day had significantly higher BMI than those who were treated with 
insulin in four or five doses a day (p < .05).  In addition, the proportion of those 
participants who were overweight was greater in the group that received two doses of 
insulin daily (27.3% vs. 0%, p = .012).  While this does not indicate that type 1 diabetes 
causes obesity, it does indicate that there is a relationship between treatment regimen and 
overweight.   
Two large intervention studies, the Diabetes Control and Complications Trial 
(DCCT) with patients with type 1 diabetes and the UK Prospective Diabetes Study 
(UKPDS) have shown that the goal of treatment for diabetes is to lower HbA1c values 
toward the normal range in order to reduce the risk of long-term complications (Purnell & 
Weyer, 2003).  In order to attain this, intensive insulin therapy is recommended.  
However, results from these and other studies have shown that with the improvement of 
glycemic control, patients often experience significant increases in body weight (Purnell 
& Weyer, 2003).  
In the DCCT study, participants who had been diagnosed with type 1 diabetes for 
1-15 years were treated either by conventional treatment (1-2 injections per day) or 
intensive treatment (multiple injections per day or continuous subcutaneous insulin 
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infusion using an external insulin pump) (The Diabetes Control and Complications Trial 
Research Group, 2001).  Those receiving intensive treatment based their insulin doses on 
the results of self-monitoring of blood glucose levels at least four times a day, meal 
content, and anticipated exercise. 
In the first year of follow-up in the DCCT trial (2001), those in the intensive 
treatment group gained significantly more weight (more than twice as much) and showed 
significant increases in BMI compared with those in the conventional treatment group.  
Weight gain was more rapid in both groups during the first year than in subsequent years 
and at nine year follow-up there was no weight loss.  Interestingly, the results in this 
study were contrary to those found by Kulenovic and colleagues (2004) who found that 
those with less intensive insulin therapy were more prone to being overweight.  However, 
while Kulenovic simply looked at the correlation between treatment and BMI, the DCCT 
trial examined weight gain prospectively, which gives a better sense of causality. 
While it is unclear why intensive management of HbA1c often results in weight 
gain, there are several mechanisms that have been suggested (Purnell & Weyer, 2003).  A 
reduction in glucosuria (the amount of sugar in the urine) has been linked with increased 
weight gain, especially for patients with a high baseline HbA1c.  Other mechanisms that 
have been suggested include reduced substrate cycling and energy expenditure, anabolic 
effects on fat cells, increased hunger in response to hypoglycemic episodes, decreased 
leptin levels, and fluid and sodium retention (Purnell & Weyer, 2003).   
Within the DCCT, the weight gain that those receiving intensive insulin therapy 
experienced was associated with significantly greater insulin resistance and higher blood 
pressure and plasma lipid levels (Purnell & Weyer, 2003).  In addition, as discussed 
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earlier, weight gain in adolescent females with type 1 diabetes is associated with reduced 
compliance with insulin treatment, restrained eating, and insulin omission (Bryden et al., 
1999).   Because intensive insulin therapy results in improved glycemic control, it is the 
treatment of choice.  However, the weight gain associated with it is associated with 
additional health risks.  This underscores the importance of examining the co-occurrence 
of overweight and type 1 diabetes in adolescent females.   
Sinha and colleagues (1996) studied a group of newly diagnosed type 1 diabetics 
(n = 9, mean age = 20.7) and a group of type 2 diabetics (n = 15, mean age = 60.7) over 
six months of insulin treatment.  They found that glycemic control improved in both 
groups, with the reduction of HbA1c being greater in the type 1 group (p < .001).  In 
addition, body weight increased more over the six months in the type 1 group than in the 
type 2 group (p < .001).  This weight gain (in the type 1 group) was attributed to an 
increase in lean body mass, primarily over the first month of treatment.  The authors 
hypothesize that the increase in lean mass may be explained, in part, by the sodium and 
water retaining effects of insulin.  They also hypothesize that the long term increase in 
lean mass may be due to a reversal of the excessive burning of energy induced by insulin 
deficiency. 
Some reasons why those with type 1 diabetes may gain excessive weight include 
overinsulinization, treating insulin reactions too frequently and in an inappropriate 
manner, trying to avoid insulin reactions by consuming extra food, and a general 
overemphasis on food intake (Tools of Therapy, 2004).  Because of all these reasons, it is 
important to consider the multiple factors that may lead to obesity in those with type 1 
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diabetes and to learn more about these factors in order to create effective prevention and 
intervention programs. 
Consequences of eating disorders and obesity in type 1 diabetes 
Eating disorders.  A subthreshold eating disorder, which may not pose risk to a 
healthy adolescent, may cause considerable problems in an adolescent with type 1 
diabetes (Nielsen, 2002).  Jones and colleagues (2000) found that adolescent females who 
have eating disorders have significantly higher HbA1c concentrations compared with 
those who do not have eating disorders.  Those with a subthreshhold eating disorder, 
however, did not have significantly different HbA1c concentrations compared to those 
with or without an eating disorder (Jones, Lawson, Daneman, Olmsted, & Rodin, 2000).  
It is unclear whether or not these analyses controlled for BMI.  Higher rates of HbA1c 
indicate impaired metabolic control which may contribute to an increased risk of 
diabetes-related complications (Jones, Lawson, Daneman, Olmsted, & Rodin, 2005).  
Therefore, comorbid type 1 diabetes and eating disorders are not only related to long-
term glycemic control, but may also be related to the development of diabetes related 
complications.   
A meta-analysis (Nielsen, 2002) found that the risk of developing retinopathy in 
those with comorbid type 1 diabetes and eating disorders is higher than in those with only 
type 1 diabetes.  In addition, Nielsen compared adolescents with concurrent eating 
disorders and type 1 diabetes to those with “brittle diabetes,” a condition in which there 
are high variations in blood sugar  (Nielsen, 2002; Leweke, Kurth, Milch, & Brosig, 
2004).  In a controlled study which compared outcomes of those with “stable” type 1 
diabetes and those with “brittle” type 1 diabetes, it was found that almost 1 in 5 of those 
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with “brittle” diabetes died after 10 years, and two-thirds of the surviving participants in 
that group had developed diabetic complications.  In the comparison group, only one-
quarter had developed complications.  Therefore, those with less metabolic control in 
type 1 diabetes (which may be affected by comorbid eating disorders) are at much greater 
risk of complications and death over time.   
Although anorexia nervosa is not more common in this population than it is in the 
general population, those who suffer from comorbid type 1 diabetes and anorexia nervosa 
are at a greater risk for death than those with either only type 1 diabetes or only anorexia 
nervosa (Nielsen, Emborg, & Molbak, 2002).  Nielsen and colleagues conducted a 
register-based study to examine this issue.  They followed 510 females with type 1 
diabetes, 658 females with anorexia nervosa and 23 females with comorbid type 1 
diabetes and anorexia nervosa over a ten year period.  They found that significantly 
higher mortality rates existed for those with anorexia nervosa than for those with type 1 
diabetes and that the probability of survival was much smaller in those with both the 
disorders than in those with just anorexia nervosa.  In addition, when those with both 
anorexia nervosa and type 1 diabetes were compared with those with just type 1 diabetes, 
the probability of survival was even smaller (p < .001).  
There is also concern with the combination of eating disorder symptomatology 
and type 1 diabetes (regardless of whether a diagnosable disorder exists).  As stated 
earlier, the most common eating disorder diagnosis concurrent with type 1 diabetes is 
ED-NOS (Jones, Lawson, Daneman, Olmsted, & Rodin, 2000) and subthreshold eating 
disorder symptoms have a greater effect on those with type 1 diabetes than on those 
without the disorder (Nielsen, 2002).   
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Obesity.  Domargard et al. (1999) examined the development of height and weight 
in a sample of 89 adolescents with type 1 diabetes and an age-matched control group of 
89 healthy adolescents.  All participants were 18 years of age when enrolled in the study 
and those with diabetes had recently been transferred from a pediatric medical practice to 
an adult medical practice.  A significant relationship was found between mean HbA1c 
during puberty and BMI at the age of 18 in diabetic girls.  Overweight females with type 
1 diabetes showed poor metabolic control before the age of 18.  This relationship 
between HbA1c and BMI may mean that the more overweight a person with type 1 
diabetes is the less metabolic control she will have.  It could also mean that less 
metabolic control can lead to overweight.  Because poor metabolic control can lead to 
additional risk factors of type 1 diabetes (Medical Encyclopedia: HbA1c, n.d.), this 
relationship (and the causal relationship of the variables) needs to be examined further.   
In a study of 592 adults with type 1 diabetes (De Block, De Leeuw, & Van Gaal, 
2005), it was found that the prevalence of overweight and obesity increased 
independently with age (p < .0001) and duration of diabetes (p = .006).  There was no 
difference between levels of HbA1c and insulin dose between normal weight and 
overweight participants.  Hypertension, retinopathy, and neuropathy were more prevalent 
in overweight participants than normal weight participants.  BMI correlated positively 
with total cholesterol, LDL cholesterol, non-HDL cholesterol, and triglycerides and 
negatively with HDL cholesterol in men, but not in women.  In addition, severity of 
retinopathy and neuropathy increased as BMI increased.  While BMI was not found to be 
an independent risk factor for insulin resistance and further complications in this study 
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(diabetes duration and HbA1c were the main determinants), it may be an important factor 
in the development of these conditions.   
Insulin and appetite 
The effect of insulin treatment on appetite is controversial (Russell et al., 2001).  
When there is a normal amount of glucose in the blood, insulin does not seem to play a 
role in appetite; however, when glucose levels are decreased, either by insulin or 
naturally, hunger and food intake are stimulated (Russell et al., 2001).  There is also some 
evidence that increased glucose levels can result in an increased perception of fullness 
and reduced hunger (Russell et al., 2001).  Because those with type 1 diabetes are in a 
constant state of regulating their blood glucose levels, they may be more affected by this 
than those without the disorder.   
Intervention studies 
 One major study has examined the effectiveness of an intervention for adolescent 
females with comorbid type 1 diabetes and eating disorders or disturbances.  Olmsted, 
Daneman, Rydall, Lawson, and Rodin (2002) conducted a randomized controlled trial to 
study this issue.  They randomized 85 females between the ages of 12 and 20 who had 
comorbid type 1 diabetes and an eating disturbance to either a psychoeducation program 
or treatment as usual.   
In order to qualify for participation, participants had to have been diagnosed with 
type 1 diabetes for at least one year and at least one of the following was required: a score 
of greater than or equal to 9 on the Drive for Thinness subscale of the Eating Disorder 
Inventory (EDI), a score of greater than or equal to 5 on the Bulimia subscale of the EDI, 
a score of greater than or equal to 1 on the Body Dissatisfaction subscale of the EDI, or 
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current or past binge eating, self-induced vomiting, laxative or diuretic use, or insulin 
omission for weight loss (measured by a modified version of the Diagnostic Survey for 
Eating Disorders (DSED)).   
Measures included a modified version of the DSED (to include intentional 
omission or under-dosing of insulin), the EDI (Drive for Thinness, Bulimia, and Body 
Dissatisfaction subscales), and a modified version of the EDE (modified to include 
diabetes-specific items and to allow distinction between diabetes-related concerns and 
eating psychopathology).  In addition, HbA1c levels were measured.  Assessments took 
place at pretreatment, 4 weeks after the end of the group, and at 6-month follow-up. 
The intervention consisted of six weekly 90-minute group sessions.  Sessions 
were conducted with both parents and their daughters at the same time in separate rooms.  
The groups included written and oral presentation of information on the nature of eating 
problems.  Content included information related to comorbid type 1 diabetes and eating 
disorders.  Strategies for change and a nondieting approach to normal eating were 
emphasized.   
Those in the intervention group showed a reduction in disturbed eating attitudes, 
which was maintained at the 6-month follow-up.  However, there was no significant 
improvement in HbA1c levels, and no significant effect on insulin omission. 
To date, there have been no intervention studies that directly address the problem 
of overweight and obesity in type 1 diabetes.  While disordered eating includes those that 
may have problems with binge eating and overweight, different issues must be 
considered when creating an intervention for this population.  The current study aims to 
identify some correlates of overweight and obesity in order to better understand this 
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problem and add to the knowledge needed in order to create interventions for this 
population. 
A recent study examined the effectiveness of a multisystemic intervention for 
adolescents with type 1 diabetes and poor glycemic control, focusing on differences 
between overweight and normal weight participants (Cakan, Ellis, Templin, Frey, & 
Naar-King, 2007).  All participants had “chronically poor metabolic control” prior to 
participating in the study.  Participants in the intervention group were provided with a 
multisystemic intervention with the goal of improving adherence and glycemic control.  
The intervention is described as “an intensive, family-centered, community-based 
psychotherapy” and involves treatment with the adolescents and their families.  
Treatment is focused on adherence-related problems and includes aspects of cognitive-
behavioral therapy, parent training, and behavioral family systems therapy. 
Results indicated that the intervention had a greater effect on metabolic control in 
normal weight adolescents than in overweight adolescents.  There was a 0.91% decrease 
in HbA1c in the normal weight intervention group and a 0.20% decrease in the 
overweight intervention group.  Interestingly, both groups showed a significant increase 
in adherence to blood glucose testing.  The authors suggest that the overweight 
participants may have more insulin resistance and, therefore, interventions for overweight 
adolescents with type 1 diabetes should focus on weight loss. 
This study underscores the importance of learning more about the population of 
adolescents with type 1 diabetes who are also overweight.  This will inform the 
development of effective interventions in order to increase glycemic control and, 
consequently, better health.      
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Possible predictors of overweight and disordered eating  
Onset and duration of type 1 diabetes.  Takii et al. (1999) compared girls with 
type 1 diabetes and concurrent bulimia nervosa (BN), or binge eating disorder (BED).  
They found that those with BN had significantly earlier onset and longer duration of both 
type 1 diabetes and binge eating than those with BED.  In addition, those with BN had 
more severe psychological and behavioral disturbances related to eating disorders, were 
more depressive and anxious, and had more medical consequences of diabetes than those 
with BED.  This may indicate that the earlier one develops type 1 diabetes, the more it 
affects eating (and potentially overweight).  The current study will examine the 
relationship between duration of type 1 diabetes and BMI. 
Treatment regimen, glycemic control, and low blood sugars.  There is some 
evidence that shows that those on a more traditional treatment regimen (2 shots/day) have 
higher BMIs than those who receive 4-5 shots/day (Kulenovic, Rasic, & Grujic, 2004).  
There is also conflicting prospective evidence that those on a more intensive insulin 
treatment regimen gain more weight over time (The Diabetes Control and Complications 
Trial Research Group, 2001).  The current study will examine the relationship between 
treatment regimen, weight gain over time, and BMI. 
Glycemic control (as measured by HbA1c) is an indicator of how well-managed a 
person’s diabetes is (Medical Encyclopedia: HbA1c, n.d).  The current study will 
examine the relationship between glycemic control, current BMI, and change in BMI 
over time.   
In addition, when people with type 1 diabetes experience low blood sugars, they 
may feel weakness, shaking, sweating, headache, nervousness, and hunger.  Eating 
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something with simple sugar is the best way to bring the blood sugar up immediately 
(Type 1 diabetes, 2005).  When feeling this way, a person may eat more than usual in 
order to try to alleviate the symptoms, which may have an affect on weight.  The current 
study will examine the relationship between frequency of low blood sugar episodes and 
BMI. 
Disordered eating attitudes and behaviors.  Past studies have examined eating 
disorders in adolescent females with type 1 diabetes using the EDE (Olmsted, Daneman, 
Rydall, Lawson, & Rodin, 2002; Bryden, et al., 1992).  Olmsted and colleagues (2002) 
used the EDE (modified to include issues specific to the diabetic population) to compare 
those with type 1 diabetes to controls and have found that there is a higher incidence of 
disordered eating in those with type 1 diabetes.  Bryden et al. (1992) found that while 
clinical eating disorder pathology was not more common in adolescents with type 1 
diabetes than controls, non-clinical eating disorder symptomatology was more common 
(and also had implications for diabetes management).  The current study will examine the 
prevalence of eating disorder characteristics in a population of adolescent females with 
type 1 diabetes and compare it to a comparison group without diabetes.   
One of the most common eating disordered behaviors in adolescent females with 
type 1 diabetes is insulin omission in order to control weight (Jones, Lawson, Daneman, 
Olmsted, & Rodin, 2000).  Insulin omission or under-use is a relatively easy way for 
diabetics to purge by allowing them to take in calories without gaining weight (Kelly, 
Howe, Hendler, & Lipman, 2005).  The current study will examine the relationship 
between frequency of insulin omission and eating disorder characteristics.   
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The Disinhibition scale of the Three Factor Eating Questionnaire (TFEQ; 
Stunkard & Messick, 1985) measures disregulation of eating in response to internal and 
external cues.  This scale has been shown to be positively correlated with stress and poor 
glycemic control in young women (ages 12-26) with type 1 diabetes (Balfour et al., 
1993).  Balfour and colleagues found that women who scored medium to high on the 
Disinhibition scale of the TFEQ were more likely to have poor glycemic control when 
perceived stress was high.  In addition, the Disinhibition scale has been shown to predict 
binge eating in those without diabetes (Marcus, Wing, & Lamparski, 1985).  The current 
study will examine the relationship between the Disinhibition scale, current BMI, and 
change in BMI over time.  
The Cognitive Restraint scale of the TFEQ measures conscious attempts to 
restrict food intake.  It has been found that girls who score higher on this measure had 
lower energy intake that those who score lower (de Lauzon et al., 2004).  In addition, 
women who had high scores on this measure reported lower total calorie intake and less 
frequent consumption of sweets than women who had lower scores (French, Jeffery, & 
Wing, 1994).  Cognitive restraint (as measured by the TFEQ) may be thought of as a 
positive characteristic those with type 1 diabetes to have because it may help with weight 
management and glycemic control.  This is opposed to restraint as measured by the 
Revised Restraint Scale (Herman & Polivy, 1980), which is generally regarded as a 
negative characteristic with regards to healthy eating and weight loss (Lowe, 2002).  The 
current study will examine the relationship between cognitive restraint, eating disorder 
characteristics, BMI, and change in BMI over time.   
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Weight cycling, defined as the amount of times and/or the amount of pounds lost 
and regained has been correlated with binge eating in a general population (Yanovski, 
1993).  Weight suppression, defined as the difference between one’s highest and lowest 
weight ever, has been shown to predict weight gain over time in both freshman college 
women (Lowe, Annunziato, et al., 2006) and in bulimics (Lowe, Davis, Lucks, 
Annunziato, & Butryn, 2006).  Because our participants are adolescents and have not 
been at their current height as long as adult participants would be, this measure of weight 
suppression may be of less value in providing information about the younger participants 
in the current study.   
Because weight cycling and weight suppression are correlated with eating 
disorders and weight gain, they may predict eating disorder characteristics in adolescent 
females with type 1 diabetes.  The current study will examine the relationship between 
weight cycling, weight suppression, and eating disorder characteristics.  Analysis of 
weight suppression is exploratory in the current study, however, because while 
maintained weight loss (measured by weight suppression) is positive, it predicts 
susceptibility to weight gain over time, which could be problematic. 
History of dieting has been shown to predict weight gain in a population of 
normal weight freshman women (Lowe, Annunziato, et al., 2006).  In addition, history of 
dieting is associated with a greater number of both healthy and unhealthy weight loss 
practices and higher rates of restrained eating (French & Jeffery, 1997).  The current 
study will examine the relationship between history of dieting and eating disorder 
characteristics. 
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While it is difficult to separate out the influence of genetics and environmental 
influences on weight, many studies have demonstrated that weight among family 
members is correlated (Bouchard, 2002).  Twin studies have found that heritability levels 
account for approximately 70% of variation in BMI.  In addition, the prevalence of 
obesity is much higher (twice as high) in families of people who are obese than in the 
general population (Bouchard, 2002). The current study will examine current parental 
body weight (through the use of silhouettes) and its relationship with participants’ current 
BMI.   
The Power of Food Scale (PFS; Lowe, Butryn, et al., 2006) measures heightened 
appetitive sensitivity to the food environment.  Because good control of type 1 diabetes 
necessitates a strong emphasis on the intake and restriction of food, we theorize that those 
with type 1 diabetes have a different relationship with food than those without the 
disorder in that they may have higher appetitive sensitivity to the food environment.  
Therefore, adolescent females with type 1 diabetes may score higher on the PFS than 
adolescent females without diabetes.  In addition, because obese binge eaters have been 
shown to score much higher on the PFS than groups of normal weight and obese non-
bingers (Lowe, Butryn, et al., 2006), we predict that PFS scores will be related to eating 
disorder characteristics, BMI, and change in BMI over time among type 1 diabetics. 
The current study 
The current study will aim to replicate previous findings that disordered eating 
attitudes and behaviors (with the exception of anorexia nervosa) and overweight are more 
prevalent in the population of adolescent females with type 1 diabetes than in adolescent 
females without the disorder.  In addition, the current study will examine several factors 
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that may help explain why disordered eating and overweight appear to be more common 
among type 1 diabetics than in various control groups.  We will examine correlates of 
disordered eating characteristics, BMI, and change in BMI over time.  The purpose of the 
study is to better understand what might differentiate those with higher and lower BMIs 
and those with higher and lower levels of disordered eating characteristics in adolescent 
females with type 1 diabetes.  While the findings will be correlational in nature, they may 
suggest new hypotheses about the nature of these relationships.  While it has been well-
documented that both eating disorders and overweight are problems in this population, it 
is unclear why.  This study aims to examine that question.  
While having type 1 diabetes is itself a risk factor for developing other medical 
problems, comorbid type 1 diabetes and eating disorders compounds the risk of 
developing further medical problems.  Because of this, it is important to identify the 
reasons behind the development of eating disorders in this population.  This study begins 
to explore that issue.  In addition, being overweight and having type 1 diabetes can 
increase the risk of developing other medical problems related to the disorder.  Because 
of this, it is important to understand why those with type 1 diabetes tend to be more 
overweight than controls, and why some are overweight and some are not.  By 
identifying correlates of overweight, we can better understand how to intervene in this 
population to help health professionals improve diabetes management and quality of life 
and reduce complications of the disorder.  
In addition, once correlates of disordered eating characteristics and overweight 
and obesity are identified, we can begin to develop empirically-based interventions for 
these populations.  Although the absolute number of adolescent females who have 
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comorbid eating disorders or obesity and type 1 diabetes is small, type 1 diabetes is one 
of the most chronic conditions of childhood and adolescence (Karvonen et al., 2000) and 
the number of those who have a concurrent eating disorder or are overweight or obese is 
therefore substantial.  Consequently, it is important to identify factors that may influence 
the development of disordered eating attitudes and behaviors or overweight in this 
population.  Once these factors are identified, we can begin to create effective 
interventions in order to decrease the risk of medical comorbidities related to type 1 
diabetes.   
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Hypotheses 
1. The level of disordered eating attitudes and behaviors and overweight in the 
current sample will be higher than the level in a comparison group of adolescent 
females without type 1 diabetes.   
(The remaining hypotheses apply only to participants with type 1 diabetes) 
2. Eating disorder characteristics will correlate positively with scores on the 
cognitive restraint, weight cycling, weight suppression, history of dieting, BMI, 
and using insulin omission for weight control.  
3. Current BMI will correlate positively with current glycemic control, appetitive 
responsiveness to the food environment, disinhibition, length of time since 
diagnosis, frequency of low blood sugars, number of shots per day, parental 
weight status, and BMI at first diagnosis.  Current BMI will correlate negatively 
with age at diagnosis and with cognitive restraint.   
4. Change in BMI over time will correlate positively with current glycemic control, 
appetitive responsiveness to the food environment, and disinhibition.  Change in 
BMI over time will correlate negatively with cognitive restraint.   
 
Exploratory hypothesis.  Because some overweight type 1 diabetics are overweight 
premorbidly and some are not overweight until after insulin treatment begins, there may 
be a difference between these two groups on disordered eating attitudes and behaviors.  
We will examine prevalence of overweight at time 1, prevalence of overweight at time 2, 
and prevalence of overweight at both time points.  We will then compare these three 
groups on eating disorder characteristics to determine any differences. 
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CHAPTER 2: METHODS 
Participants 
 Recruitment.  Participants were recruited from the pediatric endocrinology clinic 
at St. Christopher’s Hospital for Children in Philadelphia, PA and from three summer 
camps for children and adolescents with diabetes in Pennsylvania and New Hampshire.  
Potential participants were given flyers (see Appendix A) which asked participants if they 
met the inclusion criteria and asked for their participation in the research, stating that they 
would be compensated for their time.  In addition, the research team was available to 
answer any questions. 
 Inclusion and exclusion criteria.  Inclusion criteria for this study were: (1) female 
gender; (2) have been diagnosed with type 1 diabetes; (3) between the ages of 12 and 19.  
Past studies examining this population have looked at females within a similar age range 
(Olmsted, Daneman, Rydall, Lawson, & Rodin, 2002; Maharaj, Rodin, Olmsted, 
Connolly, & Daneman, 2003; Jones, Lawson, Daneman, Olmsted, & Rodin, 2005).  
Exclusion criteria for this study were: (1) male gender; (2) have been diagnosed with type 
2 diabetes; (3) Diabetes secondary to another disease or disorder (such as cystic fibrosis).   
Measures 
Weight and BMI.  Permission was granted from participants at the endocrinology 
clinic to collect height and weight information from their medical chart.  BMI was 
calculated by dividing weight in kilograms by the square of height in meters.  We 
collected this information from the medical chart instead of asking for it via self-report 
because it yields more accurate data.  BMI has been demonstrated to have adequate 
convergent validity with measures of body fat such as dual energy x-ray absorptiometry 
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(Pietrobelli et al., 1998; Dietz & Robinson, 1998).  In addition, height and weight 
information was also collected from the second time the participant was seen at the clinic 
(or the first time if the participating clinic was not the first office they visited when 
diagnosed).  Second visit height and weight data was used instead of first visit height and 
weight data because of the weight loss that often the accompanies onset of type 1 
diabetes.   
From the participants that were recruited at camp, we collected self-report (and 
parent report) height and weight data because we were unable to collect it from their 
medical charts and time constraints prohibited us from measuring their height and weight 
onsite.  We also collected information about participants’ weight category (underweight, 
normal weight, overweight, obese) prior to their diagnosis of type 1 diabetes. 
Demographics Questionnaire (Appendix B).  The Demographics Questionnaire is 
a self-report measure created by the researchers that asks participants to report 
information on their age, ethnicity, parental and sibling weights, family history of 
diabetes, age at first diagnosis of type 1 diabetes, treatment regimen, frequency and 
treatment of low blood sugar episodes, history of being overweight, and whether their 
overweight occurred prior to or after diagnosis of type 1 diabetes (if at all).    
Eating Disorder Examination – Self-Report Questionnaire Version (EDE-Q; 
Fairburn & Beglin, 1994; Appendix C).  The EDE-Q is a self-report version of the Eating 
Disorder Examination (EDE; Fairburn & Cooper 1993), a semistructured diagnostic 
interview for eating disorder symptomatology.  The EDE-Q is a 32-item self-report 
measure, which yields scores on four subscales: Restraint, Shape Concern, Weight 
Concern, and Eating Concern, as well as a global measure, which averages the four 
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subscales.  Luce and Crowther (1997) tested the internal consistency and test-retest 
reliability of the EDE-Q on a group of 139 female undergraduate students.  They found 
that all four subscales have excellent internal consistency and test-retest reliability.   
Three-Factor Eating Questionnaire Cognitive Restraint (TFEQ-CR) and 
Disinhibition (TFEQ-D) subscales (Stunkard & Messick, 1985; Appendix D).  The TFEQ 
is a self-report questionnaire designed to assess three factors of eating behavior; 
disinhibition, hunger, and restraint.  We only administered the restraint and disinhibition 
subscales.  The TFEQ-CR subscale, comprised of 21 items, measures conscious attempts 
to restrict food intake.  The TFEQ-D subscale, comprised of 16 items, measures the 
disregulation of eating in response to external and internal cues.  The measure has two 
parts: In Part I, items are rated as true or false and in Part II items are rated for agreement 
or frequency on 4- or 5-point scales.  The TFEQ has acceptable psychometric properties.  
The TFEQ-CR subscale has an internal consistency of .80 and a two-week test-retest 
reliability of .91 (Allison, Kalinsky, & Gorman, 1992).  The TFEQ-D subscale has an 
internal consistency of .91 (Stunkard & Messick, 1985).   
HbA1c.  HbA1c assesses for glycemic control.  We obtained consent from 
participants to collect this information from their medical chart (because participants may 
not know this information).  At the summer camps, we asked parents to fill out a 
questionnaire asking about their daughter’s glycemic control.   
Dieting and Weight History Questionnaire (Appendix E).  The Dieting and 
Weight History Questionnaire is a self-report measure that asks participants to report on 
their current weight, their highest weight ever, and reasons for losing weight.  In addition, 
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it asks about current and past dieting behaviors.  This measure assesses for dieting 
behaviors, weight cycling, and weight suppression.  
Power of Food Scale (PFS; Lowe et al., 2006; Appendix F).  The PFS is a 21-item 
self-report measure that assesses psychological reactions to the food environment and 
individual differences in the rewarding properties of food.  The PFS has acceptable 
reliability (Cronbach’s α = .93) and four month test-retest reliability = .80.  It also has 
acceptable validity.  It is significantly related to scores on the TFEQ Disinhibition (r = 
.54, p < .01) and Hunger (r = .52, p < .01) subscales, the Dutch Eating Behavior 
Questionnaire Emotional Eating (r = .55, p < .01) and External Eating (r = .67, p < .01) 
subscales, and the Restraint Scale (r = .30, p < .01).   
Procedure 
At the endocrinology clinic, potential participants were identified by the nurse 
practitioner based on their gender, age, and diabetes status (type 1 vs. type 2).  Flyers 
were given to these potential participants at the beginning of their visit to the clinic.  The 
researcher spoke to the potential participant and her family either prior to or following 
their visit with the doctor.  After discussing the study and answering any questions the 
family had, the researcher completed the consenting and assenting process with interested 
families.  Each family was given a copy of the consent and assent forms for their records.  
The consent form and assent form included contact information for the researcher in case 
the participant or her parents had any questions.  In order to increase the accuracy of data 
collection, it was stated in the consent and assent forms that all data collected is 
confidential.  It was also stated explicitly that the data collected from each participant 
would not be shown to her parents. 
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Participants then chose whether they preferred filling out the questionnaire online 
or using a paper copy.  If they chose the online option, they were given written and verbal 
instructions about how to complete the questionnaire.  If they chose the paper option, 
they were given the questionnaire and a stamped return envelope.  
Procedures for the summer camps were slightly modified for the different 
environment.  The research team went to the opening day of each camp and was assigned 
a table within the registration area.  Flyers were hung on the table in order to inform the 
campers and their parents about the research.  Potential participants approached the table 
and were given additional information about the study.  Once all questions were 
answered, the research team completed the consenting and assenting process with 
interested families.  The questionnaire and parent questionnaire were then given to the 
family and a quiet area was provided to complete the questionnaires.   
Compensation.  Once the data were received by the researcher, participants were 
either mailed or handed a $10 gift card to Target, depending on how data was returned.  
In addition, each participant was entered into a raffle to win an iPod Shuffle.  Once all 
data were collected, one participant was randomly chosen and sent an iPod Shuffle.   
Human subjects concerns.  Participants provided informed consent and/or assent 
for participation in this study as detailed above.  Both the consent and assent forms 
included the researcher’s contact information, as well as contact information for the 
Institutional Review Board at Drexel University.  Participants were directed to use this 
contact information if they had any concerns about the study. 
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Statistical Analyses  
 Statistical power.  To determine the number of participants needed for enrollment 
in the study, a power analysis was completed.  Power calculations were conducted for a 
simple correlation, which is the primary analysis that was used.  Using the Sample Power 
program for computing a statistical power, with an alpha of 0.05 and a medium effect 
size (r2 =.06), 82 participants are necessary to achieve power of 0.80, which is acceptable 
for behavioral research (Cohen, 1988).  This N is also sufficient for independent sample 
t-tests, which were also used for analysis.   
 Data verification.  After collection, all questionnaire forms were screened for 
missing data and unclear responses.  Some data were collected via website, which 
reduced potential for data entry error.  All other data were entered twice and 
discrepancies were identified and corrected.  Prior to analysis, all data were checked for 
out-of-range values.  Frequency distributions and graphs were generated to gather 
information on data distributions and search for unusual data points.    
  Preliminary analyses.  Several preliminary analyses were conducted.  First, 
descriptive analyses were conducted to characterize the sample.  In addition, normality of 
the variables was tested by examining normal distribution of the error and 
homoscedasticity.  All variables had acceptable outcomes.     
  Primary analyses.  Because the goal was to determine which variables best 
predicted the outcome variables, the analyses were conducted in two parts.  For each 
primary aim, correlations were first conducted between the outcome variable and the 
individual predictor variables.  When significant results were found, a multiple regression 
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was conducted in order to determine whether or not the variables were independent 
predictors of the outcome variable.   
Sample size needs for power increase with multiple regression.  For a multiple 
regression with two predictor variables, 154 participants are necessary to achieve a power 
of .80.  For a multiple regression with three predictor variables, 175 participants are 
necessary to achieve a power of .80.  These analyses were conducted using the Sample 
Power program for computing a statistical power, with an alpha of .05 and a medium 
effect size (r2 = .06).  Because a sufficiently large sample to achieve a power of .80 for all 
analyses was not achieved, the effect size of each variable entered into a multiple 
regression was reported in order to gain some knowledge of the relationship between the 
predictor and outcome variables.   
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CHAPTER 3: RESULTS 
Final sample demographics 
 Ninety five participants signed the consent form, but five did not complete the 
questionnaire.  The final sample consisted of 90 participants; 26 from the endocrinology 
clinic at St. Christopher’s Hospital for Children, 23 from the Donovan McNabb Camp for 
Kids with Diabetes, 22 from Camp Carefree, and 19 from Camp Setebaid.  Participants 
were female and between the ages of 12 and 19, inclusive.  The average age of 
participants was 14.3 (sd = 2.0), BMI ranged from 15.8 to 35.7 with an average of 23.5 
(sd = 3.9), and number of years since diagnosis with diabetes ranged from 0 to 15 with an 
average of 6.4 (sd = 4.0).  Fifty participants were on the insulin pump and 40 were taking 
multiple shots per day with an average of 3.3 (sd = 1.2).  Participants were 80% 
Caucasian, 13% African American, 4% Hispanic or Latino, and 2% more than one race.  
Ethnicity by site is shown in table 1. 
 
 
Table 1: Ethnicity by site 
 St. Christopher McNabb  Carefree Setebaid 
N  26 23 22 19 
White  13 (50.0%) 20 (87.0%) 22 (100%) 17 (89.5%) 
Hispanic/Latino  3   (11.5%) 0 0 1   (5.3%) 
Black/African American  9   (34.6%) 2   (8.7%) 0 1   (5.3%) 
More than one race 1   (3.80%) 1   (4.3%) 0 0 
 
 
Demographic variables by type of site.  Because there may have been differences 
between those participants recruited at the endocrinology clinic and those recruited at 
camps, differences in demographic variables were examined between these groups.  
Descriptive statistics are shown in table 2.  Independent samples t-tests were conducted to 
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compare continuous variables.  Significant differences were found in BMI (t(87) = 2.12, p 
= .04) and father’s weight (t(84) = 2.10, p = .04), with the participants from the 
endocrinology clinic reporting higher BMI and higher father’s weight.  A chi square 
analysis was conducted to compare difference in ethnicity between participants from the 
four sites and was significant (X2(9) = 24.10, p = .004).  In addition, a chi square analysis 
was conducted to compare ethnicity between subjects recruited from the endocrinology 
clinic and all those recruited from camps and was significant (X2(3) = 21.11, p < .001).  
This indicates that there were differences in ethnicity across all four sites and between 
those recruited from the endocrinology clinic and those recruited from camps.  Those 
recruited from camps were primarily white, while those recruited from the endocrinology 
clinic were more ethnically diverse. 
 
 
  Table 2: Demographics by type of site (Mean and SD) 
 Endocrinology Clinic  Camps 
Age 14.85  (2.19) 14.06  (1.90) 
BMI 24.82  (4.57) 22.93  (3.48) 
Age at diagnosis 8.96    (3.69) 7.38    (3.47) 
Years since diagnosis 5.88    (4.28) 6.62    (3.83) 
Mom weight 4.36    (1.29) 4.33    (1.45) 
Dad weight 5.48    (1.38) 4.68    (1.62) 
 
 
 
Differences in variables by ethnicity.  Differences in variables may occur between 
ethnicities.  Although the current sample was primarily Caucasian, we ran analyses to 
compare Caucasians and African-Americans on the major variables.  Independent 
samples t-tests were conducted to examine differences between the two groups.  None of 
the analyses were significant.  The mean and standard deviation for all variables can been 
found in table 3 below. 
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Table 3: Variables by ethnicity (Mean and SD) 
 Caucasian Black or African-American  
Age  14.11  (1.88) 14.92  (2.68) 
BMI 23.13  (3.77) 25.33  (4.75) 
HbA1c 8.21    (1.41) 9.53    (3.17) 
TFEQ-CR 7.06    (4.39) 9.09    (4.78) 
TFEQ-D 5.59    (3.79) 4.91    (1.97) 
EDE-Q Global 1.29    (1.41) 1.25    (1.49) 
PFS 38.33  (16.33) 43.00  (12.19) 
Wt. Suppression 2.57    (3.68) 4.20    (5.32) 
Wt. Cycling 31.29  (83.45) 10.00  (9.01) 
Years since diagnosis 6.14    (3.81) 6.45    (4.78) 
Mom weight 4.39    (1.44) 4.42    (1.24) 
Dad weight 4.89    (1.61) 4.40    (1.58) 
Age at diagnosis 7.96    (3.51) 8.27    (4.19) 
 
 
 
Level of disordered eating attitudes and behaviors in the current sample 
 
 It was hypothesized that the level of disordered eating attitudes and behaviors and 
overweight in the current sample would be higher than that in a comparison group of 
adolescent females without type 1 diabetes.  There have been no studies in adolescent 
females with type 1 diabetes and a comparison group using the EDE-Q.  However, 
Carter, Stewart, and Fairburn (2001) conducted a norms study for young adolescent 
females.  Carter, Stewart, and Fairburn (2001) examined EDE-Q scores in 808 adolescent 
females between the ages of 12 and 14, with an average age of 13.4. The sample was 
primarily Caucasian, although ethnicity data was not collected.  Their results on the EDE-
global score were compared with the current sample by conducting a t-test based on the 
means, standard deviation, and pooled variance from the two samples.  Results indicated 
no significant difference between the groups (t(897) = 1.86, p < .10).  Interestingly, 
although no significant difference was found, the comparison revealed a difference that 
approached significance, with the EDE-global score in the current sample lower than that 
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of the comparison group (1.3 (1.4) vs. 1.6 (1.4).  This indicates that the level of 
disordered eating in the current sample was not significantly different than that of a 
general population comparison sample.  A table with all four subscales and the global 
score of the comparison group and the current sample is shown below (table 4). 
 
 
Table 4: EDE-Q comparison scores (Mean and SD) 
EDE-Q subscales Current sample Comparison group 
Restraint 1.1 (1.4) 1.4 (1.5) 
Eating concerns .72 (1.2) 1.0 (1.0) 
Shape concerns 1.8 (1.9) 2.2 (1.7) 
Weight concerns 1.6 (1.8) 1.8 (1.7) 
Global score 1.3 (1.4) 1.6 (1.4) 
 
 
In order to compare BMI from the current sample with a non-diabetic comparison 
group, the comparison group from Jones et al., 2000 was used.  This was a group of 1098 
non-diabetic females, ages 12-19, inclusive, which was used as a comparison group in a 
study of adolescent females with diabetes.  The authors did not report ethnicity data on 
their diabetes group or on their comparison group.  The average age of the comparison 
group was 14.8 (SD = 1.9).  A t-test was conducted using the means, standard deviations, 
and pooled variance of each sample.  A significant difference was found between groups 
(t(1186) = 7.8, p < .01), with the current sample having a higher average BMI than the 
comparison group (23.5 (3.9) vs. 20.6 (3.3). 
Correlates of eating disorder characteristics  
The relationship between eating disorder characteristics and a number of variables 
was explored.  While the EDE-Q asks specific questions about bingeing and purging, 
those questions are not factored into the scoring.  Therefore, we refer to it as measuring 
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eating disorder “characteristics” and not “pathology.”  We theorized that eating disorder 
characteristics would correlate positively with cognitive restraint (as measured by the 
TFEQ-CR scale), weight cycling, weight suppression, history of dieting, BMI, and using 
insulin omission for weight control.  For these analyses, scores on all four EDE-Q 
subscales (restraint, eating concerns, shape concerns, and weight concerns), as well as the 
EDE-Q global score were used.  Because of the large number of correlations that were 
conducted, an α of .01 was used instead of .05 in order to be more stringent with the 
significance of the results (see table 5).   
 
 
 
Table 5: Correlates of EDE-Q subscales and global scale 
EDE-Q  TFEQ-CR Wt. Cycling Wt. Suppression BMI 
Restraint r=.65, p<.001** r=.15, p=.49 r=.19, p=.09 r=.37, p<.001** 
Eating concerns r=.41, p<.001** r=.23, p=.29 r=.31, p=.005* r=.39, p<.001** 
Shape concerns r=.51, p<.001** r=.34, p=.10 r=.24, p=.03 r=.58, p<.001** 
Weight concerns r=.49, p<.001** r=.28, p=.19 r=.23, p=.04 r=.56, p<.001** 
Global r=.59, p<.001** r=.30, p=.18 r=.25, p=.03 r=.51, p<.001** 
*   = significant at less than .01 
** = significant at less than .001 
 
 
 
Simple correlations were significant between the TFEQ-CR and all four subscales 
of the EDE-Q, as well as the global score (p < .001 for all correlations).  Weight 
suppression correlated significantly with the eating concerns subscale of the EDE-Q (r = 
.31, p = .005).  In addition, current BMI correlated significantly with all four subscales of 
the EDE-Q, as well as the global score (p < .001 for all correlations).  Because history of 
dieting is a dichotomous variable, an independent samples t-test was conducted, 
comparing those who do and do not have a history of dieting on eating disorder 
characteristics.  Levene’s test for equality of variances was significant, therefore, the t-
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test used assumed unequal variances.  The difference between groups was significant 
(t(25.2) = -4.3, p < .001), with those reporting a history of dieting scoring higher on the 
EDE-Q.  Only two of the participants reported using insulin omission for weight control.  
Therefore, this variable was removed from the analyses for statistical reasons.   
A multiple regression was then conducted with those variables that were 
significant in simple correlations.  The correlation of the EDE-Q global score is 
confounded with the TFEQ-CR scale because it contains a measure of restrained eating.  
Therefore, the TFEQ-CR was not included in this analysis.  EDE-Q global score was 
regressed on weight suppression and BMI and significant results were found (F(2,73) = 
12.95, p < .001, adjusted R2 = .24).  When controlling for weight suppression, BMI was 
significant in predicting EDE-Q score (β = .45, p < .001).  When controlling for BMI, 
weight suppression was no longer a significant predictor of EDE-Q score (β = .17, p = 
.10).  These results indicate that the relationship between the EDE-Q global score and the 
predictor variables is explained primarily by BMI.  
Correlates of current BMI  
It was theorized that current BMI would correlate positively with glycemic 
control (as measured by current HbA1c), appetitive responsiveness to the food 
environment (as measured by the PFS), disinhibition (as measured by the TFEQ-D), 
length of time since diagnosis, frequency of low blood sugars, number of shots per day, 
parental weight status, and BMI at first diagnosis.  It was also theorized that current BMI 
would correlate negatively with age at diagnosis and cognitive restraint (as measured by 
the TFEQ-CR).   
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Frequency of low blood sugars was measured as a categorical variable (less than 
once a week, 1-2 times a week, 2-3 times a week, 4-6 times a week, every day).  
However, because the variables are clearly ordered and because the intervals between 
variables are relatively constant, it was treated as a continuous variable in order to 
examine the relationship between this variable and current BMI.  In addition, because of 
the additional data collection at the diabetes camps, it was not possible to obtain exact 
BMI at first diagnosis with diabetes.  Instead, parents were asked to estimate their child’s 
weight category prior to their diagnosis (underweight, normal weight, overweight, obese).  
Because we did not have parental report data on this variable for the 26 participants from 
the endocrinology clinic, we calculated their BMI from their second visit to the clinic and 
assigned them to a weight category in order to utilize their data.  Although this is not the 
ideal way to conduct this analysis, because the categories are clearly ordered and have 
relatively similar intervals between them, we chose to compute the analysis in this way.   
Simple correlations were conducted and the results are shown in table 6.  
Correlations were significant between current BMI and score on the PFS (r = .23, p = 
.04), TFEQ-D score (r = .33, p = .003), and BMI category at first diagnosis (r = .44, p < 
.001).   
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Table 6: Correlates of current BMI 
 
*   = significant at less than .05 
** = significant at less than .01 
 
 
 
A multiple regression was then conducted with those variables that were 
significant.  Current BMI was regressed on scores on the PFS, TFEQ-D, and BMI 
category at first diagnosis.  Significant results were found (F(3,72) = 10.6, p < .01, adjusted 
R2= .28).  In this analysis, TFEQ-D (β = .32, p = .04) and BMI category at first diagnosis 
(β = .43, p < .001), accounted for the relationship with current BMI, while the PFS no 
longer accounted for the relationship (β = .04, p = .82).  This indicates that the 
relationship between current BMI and the predictor variables was explained by 
disinhibition and BMI category at diagnosis.   
Because greater than half of the participants were on the insulin pump, it was not 
possible to correlate number of shots per day with current BMI.  Instead, a t-test was 
conducted to compare current BMI between those who are on pump treatment with those 
who take shots.  The mean BMI for the pump group was 23.1 (sd = 3.7) and the mean 
BMI for the shots group was 24.0 (sd = 4.1).  The difference between groups was not 
  BMI 
HbA1c r=.10, p=.37 
PFS r=.23, p=.04* 
TFEQ-CR r=.17, p=.12 
TFEQ-D r=.33, p=.003** 
Time since diagnosis r=.14, p=.19 
Frequency of low blood sugars r=-.20, p=.06 
Mother’s weight r=.14, p=.19 
Father’s weight r=.09, p=.43 
BMI category at diagnosis r=.44, p<.001** 
Age at diagnosis r=.03, p=.80 
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statistically significant (t(87)= -1.14, p = .26).  This indicates that in the current sample 
treatment regimen does not influence BMI.  
Correlates of change in BMI over time 
It was theorized that change in BMI over time would correlate positively with 
glycemic control (as measured by current HbA1c), appetitive responsiveness to the food 
environment (as measured by the PFS), and disinhibition (as measured by the TFEQ-D). 
In addition, it was theorized that change in BMI over time would correlate negatively 
with cognitive restraint (as measured by the TFEQ-CR).  Because data from 71% of our 
participants were collected at diabetes camps, medical charts were not accessible.  
Therefore, we were unable to collect height and weight data from the second doctor’s 
visit.  Although retrospective parent-reported data on BMI category prior to diagnosis 
were collected, this is not sufficient to compute data on change in BMI over time.  
Therefore, we were not able to complete these analyses.  
Exploratory hypothesis 
We theorized that because some overweight type 1 diabetics are overweight 
premorbidly and some are not until after insulin treatment begins, there may be a 
difference between these groups on disordered eating attitudes and behaviors.  Because of 
the data collection methods, we were unable to use data from the medical charts to 
compute BMI.  Self-report data, however, was available to look at this.  Participants 
answered the question, “Were you overweight before or after your diagnosis of 
diabetes?” with the answer choices: a) before, b) after, c) before and after, d) I’ve never 
been overweight.  While this is not ideal, it provides some information.   
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In our sample, 3.3% reported being overweight premorbidly, 25.3% reported 
being overweight after diagnosis of diabetes, 12.1% reported being overweight at both 
time points, and 54.9% reported that they have never been overweight.  In order to 
conduct the analysis, those who were overweight premorbidly and those who were 
overweight at both time points were combined to form one group.  A one-way ANOVA 
was conducted to compare differences between the three groups on the EDE-Q global 
scale and was significant (F(2,74) = 20.3, p < .001).  To determine which groups were 
significantly different from one another, Tukey’s HSD post-hoc test was conducted 
(means of the three groups can be found in table 7).  Results indicated significant 
differences in means on EDE-Q global scores between those who were overweight before 
diagnosis and those who were never overweight, as well as between those who were 
overweight after diagnosis and those who were never overweight (p < .001 for both 
comparisons).   
 
 
Table 7: Correlations between weight status and EDE-Q 
Weight Status EDE-Q global mean and SD 
Overweight before diagnosis 2.71(1.75) 
Overweight after diagnosis 2.06(1.50) 
Never overweight 0.59(0.79) 
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CHAPTER 4: DISCUSSION 
 
This study aimed to examine the relationship between disordered eating attitudes 
and behaviors and overweight and a number of self-report measures of attitudes toward 
food, weight and dieting history, and diabetes treatment variables in adolescent females 
with type 1 diabetes.  The aim of the study was to better understand this population and to 
begin to contribute to the development of effective interventions.  Ninety adolescent 
females completed the questionnaire, yielding interesting results that may have 
implications for future interventions. 
When compared to a comparison group of non-diabetic females in the same age 
range, the current sample had a significantly higher average BMI.  This is important 
given the implications of weight on amount of insulin needed for effective glucose 
control; the more a person weighs, the more insulin is needed to regulate glucose levels.  
It should be noted that the ethnicity of the comparison group was unknown and it is 
unclear how differences in ethnicity may affect this comparison.  Both the comparison 
group and the current study (for the majority of participants) measured BMI using self-
report data and had the same age range.  This finding is consistent with past literature, 
however, it should be interpreted with caution, given that the sample group was from a 
study published in 2000 and it is likely that the data was collected at least a year prior to 
publication.  As noted earlier, prevalence of overweight has increased dramatically from 
2000 to 2005 (Sturm, 2007).  While this study notes an increase in overweight within the 
adult population, it is likely that there has been a significant increase in adolescent weight 
as well.  Therefore, although the current sample is significantly heavier, it may not be due 
to their diabetes status as much as to a general trend toward overweight.    
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As noted earlier, a significant relationship has been found between mean HbA1c 
during puberty and BMI at the age of 18 in diabetic females (Domargard et al., 1999).  
This may mean that having worse glycemic control during puberty causes weight gain, 
that something about being overweight leads to less glycemic control, or that another 
factor is influencing both glycemic control and weight.  In addition, overweight females 
with type 1 diabetes showed poorer metabolic control before the age of 18 than type 1 
diabetics who were not overweight (Domargard et al., 1999).  This indicates a 
relationship between overweight and poorer glucose and metabolic control.  Therefore, 
being overweight can affect the course of the disease negatively and should be avoided. 
In addition, the majority of the overweight participants in the current study report 
not being overweight prior to diagnosis of diabetes.  While this is a self-reported finding, 
it is still telling and may indicate that having type 1 diabetes causes these girls to become 
heavier than those who do not have the disorder.  One explanation for this may be the use 
of insulin, which has been shown to be associated with weight gain (Kulenovic, Rasic, & 
Grujic, 2004; Purnell & Weyer, 2003).  In addition, those with type 1 diabetes may gain 
weight because of trying to avoid low blood sugars by consuming extra food and because 
of a general overemphasis on food intake (Tools of Therapy, 2004).  Because of the 
tendency of type 1 diabetics to gain weight, and because of the negative implications of 
weight gain, this is an area that would benefit from further exploration.  
Interestingly, given past data reported in this area, the current sample had less 
eating disorder characteristics than a comparison group.  This finding is in contrast with 
past literature.  While both groups were primarily Caucasian, the average age of the 
comparison group was about a year younger than that of the current sample (13.4 vs. 
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14.3) and it does not appear as if the authors ruled out any participants based on health 
status.  Therefore, there may have been participants with diabetes or other chronic 
diseases in the comparison group.  In addition, the comparison group was given an EDE-
Q that was modified for the young age of participants.  The time frame was shortened 
from 28 days to 14 days and some wording was simplified (Carter, Stewart, & Fairburn, 
2001).  While this likely did not affect the results, it should be noted.  Other studies that 
have found more eating disordered behaviors have used different measures, clinical 
interviews instead of self-report, different age ranges, and different recruitment methods.   
These differences in methodology may have influenced the findings.   
The EDE-Q has not been used previously with an adolescent diabetic population 
and may not be the most accurate measure of eating disorder characteristics in adolescent 
females with type 1 diabetes.  Because the EDE-Q asks many questions about eating 
behaviors and weight and shape concerns that could be relevant to type 1 for reasons 
having nothing to do with disordered eating, these questions may be confounded with the 
behaviors necessary to maintain optimal HbA1c values.  The EDE-Q asks many 
questions about eating behaviors that are used “to influence your shape or weight.”  
When completing this measure, however, adolescents may not read the question fully and 
may answer the question regarding their eating behavior in general (which is likely 
influenced by diabetes).  One example of this is the question, “Have you tried to follow 
definite rules regarding your eating in order to influence your shape or weight; for 
example, a calorie limit, a set amount of food, or rules about what and when you should 
eat?”  If this question is read and fully comprehended, it would be clear that it is talking 
about trying to influence shape or weight.  However, if read quickly, or if the reader is 
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distracted, there is a chance they would not notice the specified intention of influencing 
shape or weight.  Adolescents with diabetes are instructed to follow definite rules 
regarding their eating for optimal glycemic control and may answer this question (and 
others on the measure) differently than those without diabetes.  Therefore, adolescent 
females with type 1 diabetes may have some eating behaviors that look disordered when 
filling out the questionnaire, but in reality are motivated by the desire to manage their 
disease effectively.  
Significant positive correlations were found between all four subscales and the 
global score of the EDE-Q and scores on the TFEQ-CR, indicating that those with higher 
eating disorder characteristics also have higher levels of cognitive restraint.  This is an 
interesting finding, given the difference in necessary eating behaviors in this population 
versus a population without diabetes.  This finding may not necessarily indicate that 
cognitive restraint is negative in this population, given the potential confounds of the 
EDE-Q as discussed previously.  Neither the EDE-Q nor the TFEQ-CR has been used 
previously in this population.  While the EDE-Q may not warrant further use in this 
population, the TFEQ-CR may have some utility as a measure that is easily completed 
and scored and may provide important information about eating attitudes and behaviors. 
Significant positive correlations were also found between all four subscales and 
the global scale of the EDE-Q and current BMI.  This indicates that those adolescents 
who have more eating disorder characteristics also have higher BMI.  Although this is a 
correlational finding and is not causal, this information may be useful for developing 
interventions.  Those with a higher BMI may be identified as more at-risk for eating 
disorder characteristics and offered an intervention to normalize attitudes toward eating.  
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It is important to note, however, that the correlations of the EDE-Q subscales with BMI 
may not be due to the presence of type 1 diabetes.  Higher BMI could lead to higher 
restraint because a person may want to try to lose weight or prevent further weight gain.  
Eating, shape and weight concerns could also be caused by having higher BMI and may 
or may not be influenced by the presence of type 1 diabetes.    
Weight suppression correlated positively with the eating concerns subscale of the 
EDE-Q.  Again, while this is not a causal finding, those adolescents who are currently 
weight suppressors may need to be more concerned about their food intake if they are 
going to keep from gaining the weight back.  They also may be able to be identified as at-
risk for having or developing eating disorder characteristics and the proper interventions 
could be put into place.  This is the first time weight suppression has been used as a 
measure in this population.  Because of the young age of the participants in the current 
study, its use may not be prudent.  However, in an older population, this measure may 
provide important information about eating concerns.   
A significant difference was found in level of eating disorder characteristics (as 
measured by the EDE-Q global score) between those who did and did not have a history 
of dieting.  This shows that those who have a history of dieting have significantly more 
eating disorder characteristics than those who do not have a history of dieting.  However, 
we cannot infer whether the eating disorder characteristics or the dieting came first.  
Research has indicated that eating disorder characteristics may indicate risk for weight 
gain, and are not causal for eating disorders (Lowe, Annunziato, et al., 2006).  This is the 
first time this specific analysis has been completed and adds to the understanding of the 
relationship between dieting and disordered eating characteristics.  While the causal 
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direction of these two variables is debatable, the fact that they are positively correlated 
indicates that the relationship should be examined further.   
Interestingly, only 20 participants (22%) reported a history of dieting.  We would 
have expected the numbers to be higher in a population of adolescent females.  Neumark-
Sztainer and Hannan (2000) found in a study of 6728 adolescents in grades 5 – 12 (boys 
and girls), 45% of the girls reported that they had been on a diet at some point.  It is 
possible that this was underreported in our sample and/or participants.  It is also possible 
that the adolescents in our study are aware of the importance of food in the management 
of their diabetes and the dangers of not eating enough and, therefore, are less likely to 
have dieted because of that.  It is interesting to note that the majority of participants 
report never being overweight.  In addition, it is important to remember that the average 
age of diagnosis in the current sample is eight years.     
The relationship between using insulin omission for weight control and eating 
disorder characteristics was not conducted because only two participants reported this 
behavior.  We suspect this was underreported, given the level reported in the current 
literature.  As stated previously, while the percentage of adolescent females with type 1 
diabetes who admit to insulin omission varies, on average, it is approximately 30% 
(Peveler et al., 2005, Bryden et al., 1999).  Studies that report higher levels of insulin 
omission or misuse to lose weight have had similar age ranges as the current study, 
however, they have all used clinical interview, which may impact the response of 
participants (Peveler et al., 2005; Bryden et al., 1999; Jones et al., 2000).  In addition, 
although the age range in the current study was 12-19, the average age was 14.3.  Rodin 
et al. (2002) report a marked difference in the amount of insulin misuse reported by age.   
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They have found one percent of girls in the preteen years endorsing this practice, 11-14% 
in the mid-teen years, and 34% of older adolescents and young adults endorsing insulin 
misuse in order to lose weight (Rodin et al., 2000).  The relatively young average age of 
our sample may explain why so few participants endorsed insulin omission to lose 
weight. 
Participants were also asked whether or not they always take the amount of 
insulin prescribed and, if not, if they take more or less.  Of the 32 girls that said they do 
not always take the amount of insulin prescribed, 16 reported that they sometimes take 
more, 10 reported that they sometimes take less, and 6 reported that they sometimes take 
more and sometimes take less insulin than prescribed.  It is possible that some of the girls 
that reported taking less than prescribed are doing this in order to control their weight.  
However, because we do not know why, we did not include these participants in an 
analysis.  Perhaps in future studies, a clinical interview would be a more accurate way to 
collect this data.   
While there are measures of disordered eating that were created specifically for 
use in a diabetic population such as the Diabetes Eating Problem Survey (DEPS; 
Antisdel, Laffel, & Anderson, 2001), we chose to use a more general measure of eating 
disorder characteristics.  The EDE-Q was chosen because one of the goals of the study 
was to compare the level of disordered eating in our sample with that of a non-diabetic 
comparison group.  In addition, the EDE-Q is a short self-report measure that was easily 
completed within the time constraints of this study. 
 Current BMI correlated positively with appetitive responsiveness to the food 
environment (PFS), disinhibition (TFEQ-D), and BMI category at first diagnosis.  When 
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these variables were entered into a multiple regression, scores on the PFS no longer 
accounted for significant variance.  The correlation between BMI at first diagnosis and 
current BMI is an interesting one.  Because most of the data used to complete the analysis 
with BMI category at diagnosis was retrospective self-report, this result should be 
interpreted with caution.  While the BMI at first diagnosis was a categorical variable and 
it does not provide as much information as would be ideal, it is telling that the higher the 
BMI at diagnosis, the higher the current BMI.  This indicates that when a diagnosis of 
type 1 diabetes is made in those with a BMI that is higher than normal, special attention 
should be paid to weight as the child grows up since losing weight over time is less likely 
than gaining weight over time.  Therefore, prevention of further weight gain is important 
since weight can influence the amount of insulin needed to be effective, as well as other 
factors, as discussed earlier.  
 While not quite a significant correlation, frequency of low blood sugars correlated 
negatively with current BMI, indicating that people with lower BMIs had a greater 
frequency of low blood sugars.  This is the reverse of what was expected: that girls with 
higher BMIs would have poorer glycemic control and therefore would have a higher 
frequency of low blood sugars.  However, data on the frequency of high blood sugars was 
not collected, which could have given more information about this relationship.  Future 
studies should collect information about the frequencies of both low and high blood sugar 
episodes.  In addition, if a person with diabetes has higher HbA1c levels, they will be 
likely to have a lower BMI because they are losing sugar in their urine. 
 This is the first time in the known literature that the EDE-Q, the TFEQ-CR scale, 
and the PFS have been used to measure eating disorder characteristics in the population 
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of adolescent females with type 1 diabetes.  In addition, this is the first time in the 
literature that history of dieting has been correlated with disordered eating characteristics 
in the literature.  While the EDE-Q may not be the most accurate measure of its kind to 
use with this population, the TFEQ-CR and the PFS may be indicated for use with this 
population in the future. 
Implications for interventions 
 Some of the results found in this study may have implications for the 
development of interventions with this population.  Adolescent females have a difficult 
time managing their diabetes, and any help that can be provided by their treatment team 
may lead to more effective management and healthier patients.  The data indicate that 
some easily recognized characteristics of adolescent females with type 1 diabetes may 
predict the likelihood of problems with disordered eating attitudes or behaviors or 
problems with overweight.  These issues may be identified and discussed with patients in 
order to prevent the development of problems in the future. 
Because of the confounds of the measure of eating disorder characteristics used 
and characteristics necessary to manage diabetes, it is unclear whether the correlation 
between cognitive restraint and eating disorder characteristics indicates that those with 
higher cognitive restraint also have more characteristics of disordered eating.  If it does, 
however, implications for treatment might be to develop an intervention to decrease 
levels of cognitive restraint without producing weight gain.  These interventions may 
consist of education regarding the importance of eating on a regular basis throughout the 
day, as well as working with participants to develop a healthy diet, and keeping food 
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records.  These interventions may involve the entire family in order to help the 
participant develop more healthy attitudes toward food.  
BMI correlated positively with appetitive responsiveness to the food environment.  
If this appetitive responsiveness to the food environment can be identified by a doctor or 
other health professional, perhaps interventions can be developed to reduce appetitive 
responsiveness to the environment or to change the personal food environment.  These 
interventions may possibly help reduce BMI or help prevent weight gain.   
The positive correlation between BMI category at diagnosis and current BMI 
indicates that those who have higher BMI at diagnosis are likely to have higher BMI 
later.  If this is the case, it would be important to identify adolescent females who are 
overweight at diagnosis of type 1 diabetes and follow their weight closely and, if 
necessary, provide early intervention.  This is especially important because once people 
gain weight, it is very difficult to lose it and keep it off.  Therefore, the prevention of the 
development of overweight should be the goal.   
Another positive correlation that was found indicated that high levels of 
disinhibition correlate positively with BMI.  While this is not a causal finding, it may 
indicate that high levels of disinhibition are a marker for susceptibility to weight gain.  If 
this is the case, those with high levels of disinhibition may benefit from a weight gain 
prevention intervention.  This may help adolescents develop more healthy eating patterns 
and a positive relationship with food.     
Although the age range in the current study was 12-19, the average age was 14.3.  
Age of participants should be taken into account when interpreting the results, as well as 
when designing future interventions. Girls at different stages of adolescence have 
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different levels of knowledge and different needs.  For example, girls in young 
adolescence may not have started worrying about their body shape or caloric intake to the 
extent that older adolescents may.  An intervention with young adolescents might focus 
more on healthy eating and how eating certain foods helps the body function at an 
optimal level, with less emphasis on calories.  An intervention with an older group of 
adolescents should take into account their knowledge of dieting, food groups, and calorie 
intake and incorporate that information into the curriculum.   
While individual interventions may be helpful, they are time consuming.  Group 
interventions may be the best way to reach as many adolescents as possible while 
providing important social support at the same time.  Groups on healthy eating with 
diabetes could be ongoing at endocrinology clinics and adolescents who are considered at 
high risk for weight gain could be referred as needed.   
Limitations of the current study 
Participants in the current sample were largely white and the average age was 14.  
The racial make-up and young age may have contributed to the results.  Replication of 
this study with a more ethnically diverse sample and with a slightly older sample may 
yield different results.  In addition, the current study only included females, primarily 
because the precedent for this type of research is to only include females.  However, 
because type 1 diabetes is equally distributed in males and females, these issues may be 
applicable to males with the disorder as well and this should be explored further. 
The current study did not collect data on socioeconomic status.  This data would 
have been a useful variable to examine, both in terms of comparing samples across the 
four sites and in relation to the predictor variables.  Future studies of this type should 
 69
include measures of SES in order to gain more demographic information from 
participants.      
While the sample size in the current study was sufficient for t-test and 
correlational analyses, it was not sufficient to yield enough power for regression analyses.  
Therefore, those analyses that did not reach significance should be replicated in the future 
with a larger sample.  
Because of recruitment difficulties, the sample was recruited from four different 
sites, three of them camps.  This precluded us from collecting height, weight, and HbA1c 
data from medical charts.  Because self-report data is less accurate, it would be ideal to 
collect data only at medical practices in order to collect this important data from the 
medical charts.  In addition, because it was unlikely that parents would remember what 
their child’s height and weight was at diagnosis, we asked for BMI category instead, 
which, statistically, does not provide us with as much information as we would have 
liked.  However, given the constraints of this study, it was necessary.  It is likely that 
parental report of this information is not accurate, given that it was, on average, six years 
prior.  There also may be differences between adolescents who attend summer camp and 
those who do not, which may affect the generalizability of the results. 
In addition, regression is subject to sampling effects.  When conducting 
regression analyses in a sample, the sample itself may account for the results and there 
may be limited generalizability.  Any significant results in the current study are subject to 
this possible effect.  Therefore, it will be important to replicate any significant findings 
with another sample in the future. 
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Future directions in research 
 Adolescent females with type 1 diabetes are an important population to study, 
given the potentially devastating medical consequences of their disease.  When blood 
glucose levels are managed well in type 1 diabetes the likelihood of developing negative 
side effects of the disease is decreased.  However, adolescent females with this disease 
are at greater risk for having eating and/or weight problems and these can greatly increase 
the risk of poorly managed diabetes which can increase morbidity and mortality.  By 
learning more about this population and beginning to make causal associations between 
variables, we can develop interventions to keep this population healthier.  Future research 
should seek to identify ways to target those adolescent females with type 1 diabetes that 
are at high risk for the development of disordered eating attitudes or behaviors or weight 
gain.  Once these are developed, endocrinologists or nurses can take a few minutes to 
evaluate the risk of each patient and, if necessary, assign them to an intervention to 
reduce their risk.  Only by being able to identify those at high-risk will doctors be able to 
help those who have the greatest need.  In addition, effective interventions need to be 
developed and tested with this population in order to reduce the risk of weight gain 
and/or the development of disordered eating attitudes and behaviors. 
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APPENDIX A: RECRUITMENT FLYER 
 
 
Would you like to participate in a research study 
and earn a $10 gift card to Target?  
 
You are eligible to participate if you are: 
9 Female 
9 Diagnosed with type 1 diabetes 
9 12-19 years old 
 
 
This study requires you to fill out a packet of 
questionnaires which takes approximately 30-45 
minutes to complete.  You can complete it here or 
take it home and mail it back. 
 
If you are interested, please tell your doctor or 
the receptionist, or call 215-762-1850 and ask for 
Jessica. 
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APPENDIX B: DEMOGRAPHICS QUESTIONNAIRE 
 
 
 
DEMOGRAPHICS QUESTIONNAIRE 
 
1. Age:  __________ yrs. 
 
2. Ethnicity:  White   Asian 
  Hispanic or Latino  Native Hawaiian or Other Pacific islander  
  Black or African American  American Indian/Alaska Native 
More than one race 
 
3. Please indicate which number picture most resembles the weight of your mother: _______ 
 
 
 
 
 
 
 
 
 
 
 
4. Please indicate which number picture most resembles the weight of your father: _______ 
 
 
 
 
 
 
 
 
 
 
 
5. Do you have any siblings?   No   Yes 
 
6. If so, please indicate which number picture(s) most closely resemble their weight (using the 
pictures from above):  
________ sister  ________ sister  ________ sister  
________ brother ________ brother ________ brother  
 
7. How old were you when you were diagnosed with diabetes?  __________ yrs. 
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8. How often do you have low blood sugar episodes that require treatment? 
 Less than once a week 
 1-2 times a week 
 2-3 times a week 
 4-6 times a week 
 Every day 
 
9. When you have low blood sugar episodes, how do you usually treat them? 
 Glucose tabs  Candy 
 Juice   Whatever food is around 
 
10. Do you ever feel that you are eating a large amount of food in response to a low blood sugar? 
 No   Yes 
 
11. What type(s) of insulin do you take? (please check all that apply)  
 Humalog    NPH  Lantus  Novolog  
 Other (please specify) ______________________________________________________ 
 
12. What type of treatment do you use? 
 Insulin pump  Shots 
 
13. If you take shots, how many do you usually take a day? 
 1  2  3  4  5 
 
14. How often do you miss an insulin dosage? (approximately) 
 once a day  once a week   once a month  less than once a month  
 
15. Why do you usually miss a dose of insulin? 
 I forget    I’m trying to lose weight     I don’t want others to see me take insulin  
 
16. Have you missed an insulin dosage over the past four weeks? 
 No   Yes 
 
17. Do you… 
 Take the same dose of insulin each day? 
 Adjust your insulin dosage from day to day? 
 
18. Do you always take the exact dosage of insulin than your doctor prescribes? 
 No   Yes 
 
19. If no, do you sometimes take a little more insulin or a little less insulin than your doctor 
prescribes? 
 More  Less 
 
20. If you sometimes take a little more or a little less insulin than prescribed, why? 
_________________________________________________________________________ 
 
21. Have you done this in the past 4 weeks? 
 No   Yes 
 
22. Have you ever considered yourself overweight?      No  Yes  
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23. If so, how old were you when you or others considered you overweight? 
_______________________ 
 
24. Were you overweight before or after your diagnosis of diabetes?  
 Before  After   Before and after  I’ve never been overweight 
 
25. Please indicate with an “x” which of your family members have or had diabetes (type 1 or 
type 2) 
 
 Have/had diabetes Indicate type 1 or 2 
if known 
Sister    
Brother   
Mother   
Father   
Grandfather   
Grandmother   
Aunt   
Uncle   
Other (please specify):______________   
 
26. How many cigarettes to you smoke (on average) a day? 
 0  1-4     5-9   10-14   15 + 
 
27. How tall are you? _____ ft _____ in 
 
28. How much do you currently weigh? _______ lbs. 
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APPENDIX C: EDE-Q 
 
Instructions 
The following questions are concerned with the past four weeks only (28 days).  Please read each question 
carefully and circle the appropriate answer number on the right.  Please answer all the questions. 
 
 
ON HOW MANY DAYS OUT   No 1-5      6-12     13-15     16-22       23-27     Every 
OF THE PAST 28 DAYS:              days    days     days      days      days        days        day 
1.  Have you been deliberately        0  1   2 3 4 5   6 
     trying to limit the amount 
     of food you eat to influence 
     your shape or weight? 
2.  Have you gone for long     0  1   2 3 4 5   6 
     periods of time (8 hours or 
     more) without eating  
     anything in order to influence  
     your weight and shape? 
3.  Have you tried to avoid     0  1   2 3 4 5   6 
     eating any foods which you  
     like in order to influence your  
     shape or weight? 
4.  Have you tried to follow        0  1   2 3 4 5   6 
     definite rules regarding your  
     eating in order to influence your  
     shape or weight; for example, a calorie 
     limit, a set amount of food, or rules about  
     what and when you should eat? 
5.  Have you wanted your stomach     0  1   2 3 4 5   6 
     to be empty? 
6.  Has thinking about food or       0  1   2 3 4 5   6 
     its calorie content made it  
     much more difficult to concentrate  
     on things are interested in; for  
     example, reading, watching TV,  
     or following a conversation? 
7.  Have you been afraid of losing      0  1   2 3 4 5   6 
     control over eating? 
8.  Have you had episodes of binge     0  1   2 3 4 5   6 
     eating? 
9.  Have you eaten in secret?       0  1   2 3 4 5   6 
     (Do not count binges) 
10. Have you definitely wanted       0  1   2 3 4 5   6 
      your stomach to be flatter? 
11.  Has thinking about shape or       0  1   2 3 4 5   6 
      weight made it more difficult  
      to concentrate on things you are  
      interested in; for example, reading, 
      watching TV, or following a conversation? 
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ON HOW MANY DAYS OUT   No 1-5      6-12     13-15     16-22       23-27     Every 
OF THE PAST 28 DAYS:              days    days     days      days      days        days        day 
12. Have you had a definite fear     0  1   2 3 4 5   6 
      that you might gain weight or  
      become fat? 
13. Have you felt fat?      0  1   2 3 4 5   6 
14. Have you had a strong desire     0  1  2 3 4 5   6 
      to lose weight? 
15. On what proportion of times     0  1   2 3 4 5   6 
      that you have eaten have  None    A few      Less      Half        More     Most Every 
      you felt guilty because  of the    of the      than       the          than       of the       time 
      of the effect on your shape  times    times half       times       half       time 
      or weight? (Do not count binges.)  the               the              
     Circle the number which applies.  times  times 
16. Over the past four weeks   0   1 
     (28 days), have there been NO YES 
     any times when you have felt  
     that you have eaten what other  
     people would regard as an unusually  
     large amount of food given the  
     circumstances?  Please circle the  
     appropriate response. 
17. How many such episodes    
      have you had over the past  
      four weeks?  Please put  
      appropriate number in box.   
18. During how many of these  
      episodes of overeating did  
      you have a sense of having  
      lost control over your eating?  
     Please put appropriate number in box. 
19. Have you had other episodes      0   1 
      of overeating in which you    NO YES 
      have had a sense of having lost  
      control and eaten too much,  
      but have not eaten an unusually  
      large amount of food given the  
      circumstances? 
20. How many such episodes have  
      you had over the past four weeks? 
 
21. Over the past four weeks (28 days),  
      how many times have you made  
      yourself sick (vomit) as a means  
     of controlling your shape or weight? 
22. Over the past four weeks (28 days),  
      how many times have you taken  
      laxatives as a means of controlling  
      your shape and weight? 
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23. Over the past four weeks (28 days),  
      how many times have you taken  
      diuretics (water tablets) as a means  
      of controlling your weight? 
24. Over the past four weeks (28 days),  
      how many times have you exercised  
      hard as a means of controlling your  
      shape and weight? 
 
DURING THE PAST  No  Some            Moderate               Supreme 
      28 DAYS…           Importance             Importance          Importance             Importance 
25. Has your weight influenced 0  1   2 3 4 5   6 
      how you think about (judge) 
      yourself as a person? 
26. Has your shape influenced 0  1   2 3 4 5   6 
      how you think about (judge) 
      yourself as a person? 
 
 
 
SEVERITY   0  1   2 3 4 5   6 
              Not at all            Slightly         Moderately          Markedly 
27. How much would it upset 0  1   2 3 4 5   6 
      you if you had to weigh  
      yourself once a week for  
      the next four weeks? 
28. How dissatisfied have you 0  1   2 3 4 5   6 
      felt about your weight? 
29. How dissatisfied have you 0  1   2 3 4 5   6 
      felt about your shape? 
30. How concerned have you 0  1   2 3 4 5   6 
      been about other people  
      seeing you eat? 
31. How uncomfortable have you 0  1   2 3 4 5   6 
      felt seeing your body; for  
      example, in shop window reflections,  
      while undressing or taking a bath or shower? 
32. How uncomfortable have you 0  1   2 3 4 5   6 
      felt about others seeing your body;  
      for example, in communal changing  
      rooms, when swimming, or wearing 
      tight clothes? 
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APPENDIX D: TFEQ (COGNITIVE RESTRAINT & DISINHIBITION) 
 
 
Read each of the following statements carefully.  If you agree with the statement, or feel that it is 
true as applied to you, write “T” next to the question.  If you disagree with the statement, or feel 
that it is false as applied to you, write “F” next to the question.  Be certain to answer each 
question.  
 
_____1.  When I smell a sizzling steak or see a juicy piece of meat, I find it very difficult to  
   keep from eating, even if I have just finished a meal.      
 
_____2.  I usually eat too much at social occasions, like parties and picnics.      
  
_____3.  When I have eaten my quota of calories, I am usually good about not eating any  
   more.     
 
_____4.  I deliberately take small helpings as a means of controlling my weight.      
 
_____5.  Sometimes things just taste so good that I keep on eating even when I am no longer  
  hungry.     
 
_____6.  When I feel anxious, I find myself eating.       
 
_____7.  Life is too short to worry about dieting.       
 
_____8.  Since my weight goes up and down, I have gone on reducing diets more than once.  
_____9.  When I am with someone who is overeating, I usually overeat too.        
       
_____10.  I have a pretty good idea of the number of calories in common foods.      
  
_____11.  Sometimes when I start eating, I just can’t seem to stop.       
 
_____12.  It is not difficult for me to leave something on my plate.       
 
_____13.  While on a diet, if I eat a food that is not allowed, I consciously eat less for a  
    period of time to make up for it.       
 
_____14.  When I feel blue, I often overeat.        
 
_____15.  I enjoy eating too much to spoil it by counting calories or watching my weight. 
   
_____16.  I often stop eating when I am not really full as a conscious means of limiting the  
    amount that I eat.       
 
_____17.  My weight has hardly changed at all in the last ten years.        
 
_____18.  When I feel lonely, I console myself by eating.      
 
_____19.  I consciously hold back at meals in order not to gain weight.  
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_____20.  I eat anything I want, any time I want.    
 
_____21.  Without even thinking about it, I take a long time to eat.     
 
_____22.  I count calories as a conscious means of controlling my weight. 
 
_____23.  I do not eat some foods because they make me fat.     
 
_____24.  I pay a great deal of attention to changes in my figure.      
 
_____25.  While on a diet, if I eat a food that is not allowed, I often then splurge and eat other  
    high calorie foods.  
 
 
PART II 
 
Each question in this section is followed by a number of answer options.  After reading each 
question carefully, please circle the letter that corresponds to the option which most applies to 
you.  Be certain to answer all questions.   
 
26. How often are you dieting in a conscious effort to control your weight? 
a rarely 
b sometimes 
c usually 
d always 
 
27.   Would a weight fluctuation of 5 lbs. affect the way you live your life? 
a not at all 
b slightly 
c moderately 
d very much 
 
28. Do your feelings of guilt about overeating help you to control your food intake? 
a  never 
b rarely 
c often 
d always 
 
29. How conscious are you of what you are eating? 
a not at all 
b slightly 
c moderately 
d extremely 
 
30. How frequently do you avoid “stocking up” on tempting foods? 
 a almost never 
b seldom 
c usually 
d almost always 
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31. How likely are you to shop for low calorie foods? 
a unlikely 
b slightly likely 
c moderately likely 
d very likely 
 
32. Do you eat sensibly in front of others and splurge alone?  
 a never 
b rarely 
c often 
d always 
 
33. How likely are you to consciously eat slowly in order to cut down on how much you  
eat? 
 a  unlikely   
b slightly likely 
c moderately likely 
d very likely 
 
34. How likely are you to consciously eat less than you want? 
a unlikely 
b slightly likely 
c moderately likely 
d very likely 
 
35. Do you go on eating binges even though you are not hungry?  
a never 
b rarely 
c sometimes 
d at least once a week 
 
36. On a scale of 0 to 5, where 1 means no restraint in eating (eat whatever you want, 
whenever you want it) and 5 means total restraint (constantly limiting food intake and 
never “giving in”), what number would you give yourself? 
0 eat whatever you want, whenever you want it 
1  usually eat whatever you want, whenever you want it 
2  often eat whatever you want, whenever you want it 
3  often limit food intake, but often “give in” 
4 usually limit food intake, rarely “give in” 
5 constantly limiting food intake, never “giving in” 
 
37. To what extent does this statement describe your eating behavior? 
 
“I start dieting in the morning, but because of any number of things that happen during the day, 
by evening I have given up and eat what I want, promising myself to start dieting again 
tomorrow.” 
 a not like me 
b little like me 
c pretty good description of me 
d describes me perfectly 
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APPENDIX E: DIET AND WEIGHT HISTORY QUESTIONNAIRE 
 
1.  What is the most you have ever weighed since reaching your current height? (do not count any 
weight gains due to medical conditions or medications)?    The most I have weighed since 
reaching my current height is:  _______ pounds 
 
2.  What is your current weight?  _______ pounds 
 
3.  Please determine the difference between your answer to number 1 and number 2.  If this 
difference is less than 5 lbs. skip this item and go on to item 4.  If this difference is 5 lbs. or more, 
indicate which of the three following statements best describe this difference:  
 
 A.  The difference between my highest weight and my current weight exists because I  
       lost weight on purpose. 
 
B. The difference between my highest weight and my current weight exists because I 
lost weight even though I wasn’t trying to. 
 
C.  I’m not sure why I weigh less than I once did. 
 
4.  For about how long have you been at or close (with 2 lbs.) to your present weight? ______ 
 
5.   Are you currently on a diet?  Yes   No  (If no, go to number 7).  
 
6.  Are you currently dieting to lose weight or to avoid gaining weight?  
 
   To lose weight (go to #8)      To avoid gaining weight (go to #8) 
 
7.  Have you ever been on a diet to control your weight?     
 Yes       No (skip 8 & 9, go to the next part)                                                                                           
 
8.  About how old were you when you went on your first diet?   ______ years old 
 
9.  Please estimate as best you can the number of times in your life you have dieted and purposely 
lost the amount of weight listed.  
 
How many times in your life have you dieted and lost:  
 
1-4 pounds?  ____ times 
 
5-10 pounds?  ____ times 
 
11-20 pounds?  ____ times 
 
21 or more pounds?  ____ times 
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APPENDIX F: PFS 
 
Please indicate the extent to which you agree that the following items describe you.  Use the 
following a-e scale for your responses and write them next to each question. 
 
a  don’t agree at all 
b agree a little  
c agree somewhat 
d agree 
e  strongly agree 
________________________________________________________________ 
 
_____1.   I find myself thinking about food even when I’m not physically hungry.   
 
_____2.   When I’m in a situation where delicious foods are present but I have to wait to 
eat them, it is very difficult for me to wait. 
 
_____3.   I get more pleasure from eating than I do from almost anything else. 
 
_____4.   I feel that food is to me like liquor is to an alcoholic.  
 
_____5.   If I see or smell a food I like, I get a powerful urge to have some.   
 
_____6.    When I’m around a fattening food I love, it’s hard to stop myself from at  
least tasting it.    
 
_____7.    I often think about what foods I might eat later in the day. 
 
_____8.    It’s scary to think of the power that food has over me. 
 
_____9.   When I taste a favorite food, I feel intense pleasure. 
 
_____10.   When I know a delicious food is available, I can’t help myself from thinking  
         about having some. 
 
_____11.   I love the taste of certain foods so much that I can’t avoid eating them even if   
         they’re bad for me. 
 
_____12.   When I see delicious foods in advertisements or commercials, it makes me want 
to eat. 
 
_____13.   I feel like food controls me rather than the other way around. 
 
_____14. Just before I taste a favorite food, I feel intense anticipation.  
 
_____15. When I eat delicious food I focus a lot on how good it tastes.  
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_____16.   Sometimes, when I’m doing everyday activities, I get an urge to eat “out of the 
blue (for no apparent reason).   
 
_____17. I think I enjoy eating a lot more than most other people. 
 
_____18.    Hearing someone describe a great meal makes me really want to have something 
to eat. 
 
_____19. It seems like I have food on my mind a lot.   
 
_____20.    It’s very important to me that the foods I eat are as delicious as possible. 
 
_____21.    Before I eat a favorite food my mouth tends to flood with saliva.   
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APPENDIX G: PARENT QUESTIONNAIRE 
 
 
 
1.  How tall is your child? ____ ft. _____ in. 
 
2.  How much does your child weigh? ______ lbs. 
 
3.  Prior to your child’s diagnosis of diabetes (and before any weight loss that may have 
occurred when she started getting sick), was she: 
 
 Underweight 
 Normal weight 
 Overweight 
 Obese 
 
4. During the first year of your child’s diabetes, what was her  
average HbA1c? ______      I don’t remember 
 
5. If you don’t remember the number, was her glucose control: 
 
 Poor 
 Average 
 Good 
 I don’t remember 
 
6. What was your child’s last HbA1c? _______    I don’t remember 
 
7. If you don’t remember the number, was her glucose control: 
  Poor 
  Average 
  Good 
  I don’t remember 
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